Home
  >  
Section 10

EurekaMag Full Text Articles Chapter 9,433



References:

Severina, I.S. 1994: Soluble guanylate cyclase of platelets: Significance of heme in the mechanism of enzyme regulation and role of the enzyme in platelet aggregation. Biokhimiya 59(3): 325-339
Severina, I.S. 1995: Soluble guanylate cyclases: Mechanisms of nitrogen oxide activation, role in platelet aggregation. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1995(2): 41-46
Frantzen, F.; Grimsrud, K.; Heggli, D.E.; Sundrehagen, E. 1997: Soluble highly coloured phenylboronic acids and their use in glycohemoglobin quantification. Clinica Chimica Acta; International Journal of Clinical Chemistry 263(2): 207-224
Swift, A.J.; Collins, T.S.; Bugelski, P.; Winkelstein, J.A. 1994: Soluble human complement receptor type 1 inhibits complement-mediated host defense. Clinical and Diagnostic Laboratory Immunology 1(5): 585-589
Ra, C.; Kuromitsu, S.; Hirose, T.; Yasuda, S.; Furuichi, K.; Okumura, K. 1993: Soluble human high-affinity receptor for IgE abrogates the IgE-mediated allergic reaction. International Immunology 5(1): 47-54
Weiergräber, O.; Hemmann, U.; Küster, A.; Müller-Newen, G.; Schneider, J.; Rose-John, S.; Kurschat, P.; Brakenhoff, J.P.; Hart, M.H.; Stabel, S. 1995: Soluble human interleukin-6 receptor. Expression in insect cells, purification and characterization. European Journal of Biochemistry 234(2): 661-669
Russwurm, G.P.; Mackler, A.M.; Fagoaga, O.R.; Brown, W.S.; Sakala, E.P.; Yellon, S.M.; Nehlsen-Cannarella, S.L. 1997: Soluble human leukocyte antigens, interleukin-6, and interferon-gamma during pregnancy. American Journal of Reproductive Immunology 38(4): 256-262
Subramanyam, M.; Wands, G.; Nabioullin, R.; Tepper, M.A. 1998: Soluble human lymphocyte activation gene-3 modulates allospecific T cell responses. International Immunology 10(5): 679-689
Higazi, A.A.; Mazar, A.; Wang, J.; Quan, N.; Griffin, R.; Reilly, R.; Henkin, J.; Cines, D.B. 1997: Soluble human urokinase receptor is composed of two active units. Journal of Biological Chemistry 272(8): 5348-5353
Mohapatra, S.; Yang, X.; Wright, J.A.; Turley, E.A.; Greenberg, A.H. 1996: Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression. Journal of Experimental Medicine 183(4): 1663-1668
Valenzano, K.J.; Remmler, J.; Lobel, P. 1995: Soluble insulin-like growth factor II/mannose 6-phosphate receptor carries multiple high molecular weight forms of insulin-like growth factor Ii in fetal bovine serum. Journal of Biological Chemistry 270(27): 16441-16448
Scott, C.D.; Ballesteros, M.; Madrid, J.; Baxter, R.C. 1996: Soluble insulin-like growth factor-II/mannose 6-P receptor inhibits deoxyribonucleic acid synthesis in cultured rat hepatocytes. Endocrinology 137(3): 873-878
Bozzo, C.; Bellomo, G.; Silengo, L.; Tarone, G.; Altruda, F. 1997: Soluble integrin and growth factors independently rescue neuroblastoma cells from apoptosis under nonadherent conditions. Experimental Cell Research 237(2): 326-337
Phocas, I.; Sarandakou, A.; Giannaki, G.; Malamitsi-Puchner, A.; Rizos, D.; Zourlas, P.A. 1998: Soluble intercellular adhesion molecule-1 in newborn infants. European Journal of Pediatrics 157(2): 153-156
Shiota, Y.; Wilson, J.G.; Marukawa, M.; Ono, T.; Kaji, M. 1996: Soluble intercellular adhesion molecule 1 (ICAM-1) antigen in sera of bronchial asthmatics. Chest 109(1): 94-99
Viac, J.; Gueniche, A.; Faure, M.; Claudy, A. 1993: Soluble intercellular adhesion molecule 1 (sICAM-1) and malignant melanoma. Cancer Letters 72(3): 191-194
Aoki, S.; Imai, K.; Yachi, A. 1993: Soluble intercellular adhesion molecule-1 (ICAM-1) antigen in patients with rheumatoid arthritis. Scandinavian Journal of Immunology 38(5): 485-490
Shijubo, N.; Imai, K.; Shigehara, K.; Hirasawa, M.; Tsujisaki, M.; Hinoda, Y.; Abe, S. 1995: Soluble intercellular adhesion molecule-1 (ICAM-1) in sera and bronchoalveolar lavage (BAL) fluids of extrinsic allergic alveolitis. Clinical and Experimental Immunology 102(1): 91-97
Shijubo, N.; Imai, K.; Shigehara, K.; Honda, Y.; Koba, H.; Tsujisaki, M.; Hinoda, Y.; Yachi, A.; Ohmichi, M.; Hiraga, Y. 1994: Soluble intercellular adhesion molecule-1 (ICAM-1) in sera and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Clinical and Experimental Immunology 95(1): 156-161
Lhotta, K.; Schlögl, A.; Kronenberg, F.; Joannidis, M.; König, P. 1997: Soluble intercellular adhesion molecule-1 (ICAM-1) in serum and urine: correlation with renal expression of ICAM-1 in patients with kidney disease. Clinical Nephrology 48(2): 85-91
Giavazzi, R.; Nicoletti, M.I.; Chirivi, R.G.; Hemingway, I.; Bernasconi, S.; Allavena, P.; Gearing, A.J. 1994: Soluble intercellular adhesion molecule-1 (ICAM-1) is released into the serum and ascites of human ovarian carcinoma patients and in nude mice bearing tumour xenografts. European Journal of Cancer 30A(12): 1865-1870
Søndergaard, K.; Stengaard-Pedersen, K.; Zachariae, H.; Heickendorff, L.; Deleuran, M.; Deleuran, B. 1998: Soluble intercellular adhesion molecule-1 (sICAM-1) and soluble interleukin-2 receptors (sIL-2R) in scleroderma skin. British Journal of Rheumatology 37(3): 304-310
Zaman, A.G.; Edelsten, C.; Stanford, M.R.; Graham, E.M.; Ellis, B.A.; Direskeneli, H.; D'Cruz, D.P.; Hughes, G.R.; Dumonde, D.C.; Wallace, G.R. 1994: Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis. Clinical and Experimental Immunology 95(1): 60-65
Balázs, C.; Kiss, E. 1994: Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease. Acta Microbiologica et Immunologica Hungarica 41(4): 451-456
Koide, M.; Tokura, Y.; Furukawa, F.; Takigawa, M. 1994: Soluble intercellular adhesion molecule-1 (sICAM-1) in atopic dermatitis. Journal of Dermatological Science 8(2): 151-156
Machold, K.P.; Kiener, H.P.; Graninger, W.; Graninger, W.B. 1993: Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus. Clinical Immunology and Immunopathology 68(1): 74-78
Tulek, N.; Aydintug, O.; Ozoran, K.; Tutkak, H.; Duzgun, N.; Duman, M.; Tokgoz, G. 1996: Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with systemic lupus erythematosus. Clinical Rheumatology 15(1): 47-50
Heufelder, A.E.; Bahn, R.S. 1993: Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases. Clinical and Experimental Immunology 92(2): 296-302
Kaihara, A.; Iwagaki, H.; Gouchi, A.; Hizuta, A.; Isozaki, H.; Takakura, N.; Tanaka, N. 1998: Soluble intercellular adhesion molecule-1 and natural killer cell activity in gastric cancer patients. Research Communications in Molecular Pathology and Pharmacology 100(3): 283-300
Favaro, D.; Santarosa, M.; Quaia, M.; Spada, A.; Freschi, A.; Talamini, R.; Galligioni, E. 1995: Soluble intercellular adhesion molecule-1 and serum cytokines in melanoma patients treated with liposomes containing muramyl tripeptide. Tumori 81(3): 185-190
Hirai, S.; Kageshita, T.; Kimura, T.; Tsujisaki, M.; Okajima, K.; Imai, K.; Ono, T. 1996: Soluble intercellular adhesion molecule-1 and soluble E-selectin levels in patients with atopic dermatitis. British Journal of Dermatology 134(4): 657-661
Koch, A.E.; Shah, M.R.; Harlow, L.A.; Lovis, R.M.; Pope, R.M. 1994: Soluble intercellular adhesion molecule-1 in arthritis. Clinical Immunology and Immunopathology 71(2): 208-215
Rieckmann, P.; Nünke, K.; Burchhardt, M.; Albrecht, M.; Wiltfang, J.; Ulrich, M.; Felgenhauer, K. 1993: Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier. Journal of Neuroimmunology 47(2): 133-140
Reinhardt, K.M.; Steiner, M.; Zillig, D.; Nagel, H.R.; Blann, A.D.; Brinckmann, W. 1996: Soluble intercellular adhesion molecule-1 in colorectal cancer and its relationship to acute phase proteins. Neoplasma 43(2): 65-67
Viganò, P.; Fusi, F.; Gaffuri, B.; Bonzi, V.; Ferrari, A.; Vignali, M. 1998: Soluble intercellular adhesion molecule-1 in ovarian follicles: Production by granulosa luteal cells and levels in follicular fluid. Fertility and Sterility 69(4): 774-779
Sprenger, A.; Schardt, C.; Rotsch, M.; Zehrer, M.; Wolf, M.; Havemann, K.; Heymanns, J. 1997: Soluble intercellular adhesion molecule-1 in patients with lung cancer and benign lung diseases. Journal of Cancer Research and Clinical Oncology 123(11-12): 632-638
Lim, A.G.; Jazrawi, R.P.; Ahmed, H.A.; Levy, J.H.; Zuin, M.; Douds, A.C.; Maxwell, J.D.; Northfield, T.C. 1994: Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: Relationship with disease stage, immune activity and cholestasis. Hepatology 20(4 Pt 1): 882-888
Sonnante, A.M.; Cozzolongo, R.; Cuppone, R.; De Michele, G.; Manghisi, O.G.; Quaranta, M. 1997: Soluble intercellular adhesion molecule-1 in sera from patients with chronic hepatitis C undergoing interferon treatment. Archives of Virology 142(3): 567-569
Becker, J.C.; Termeer, C.; Schmidt, R.E.; Bröcker, E.B. 1993: Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. Journal of Immunology 151(12): 7224-7232
Schopf, R.E.; Naumann, S.; Rehder, M.; Morsches, B. 1993: Soluble intercellular adhesion molecule-1 levels in patients with psoriasis. British Journal of Dermatology 128(1): 34-37
Maeda, Y.; Chihara, J.; Sumimoto, Y.; Yamada, H.; Miyatake, J.I.; Matsuda, M.; Horiuchi, F.; Irimajiri, K.; Horiuchi, A. 1997: Soluble intercellular adhesion molecule-1 levels of patients with acute myeloid leukemia after allogeneic bone marrow transplantation. Journal of Allergy and Clinical Immunology 100(6 Part 2): S77-S78
Barnett, C.C.; Moore, E.E.; Moore, F.A.; Biffl, W.L.; Partrick, D.A. 1996: Soluble intercellular adhesion molecule-1 provokes polymorphonuclear leukocyte elastase release by CD18. Surgery 120(2): 395-401; Discussion 401-2
Airoldi, L.; Gaffuri, B.; Rossi, G.; Iurlaro, E.; Nozza, A.; Viganò, P.; Vignali, M. 1998: Soluble intercellular adhesion molecule-1 serum profile in physiologic and preeclamptic pregnancy. American Journal of Reproductive Immunology 39(3): 183-188
Tsuji, K. 1992: Soluble intercellular adhesion molecule-i levels in sera of patients with Kawasaki disease. Arerugi 41(10): 1507-1514
Novick, D.; Cohen, B.; Rubinstein, M. 1992: Soluble interferon-alpha receptor molecules are present in body fluids. Febs Letters 314(3): 445-448
Alcamí, A.; Smith, G.L. 1996: Soluble interferon-gamma receptors encoded by poxviruses. Comparative Immunology Microbiology and Infectious Diseases 19(4): 305-317
Duan, Z.F. 1993: Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma. Zhonghua Zhong Liu Za Zhi 15(1): 17-19
Smid, W.M.; Martens, A.; van der Meer, J.; Hegge-Paping, C.S.; Halie, M.R. 1997: Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate. Transfusion 37(1): 86-89
Shu, K.H.; Lu, Y.S.; Cheng, C.H.; Lian, J.D. 1998: Soluble interleukin 2 receptor in dialyzed patients. Artificial Organs 22(2): 142-144
Zorn, U.; Dallmann, I.; Grosse, J.; Kirchner, H.; Poliwoda, H.; Atzpodien, J. 1994: Soluble interleukin 2 receptors abrogate IL-2 induced activation of peripheral mononuclear cells. Cytokine 6(4): 358-364
Ina, Y.; Takada, K.; Sato, T.; Yamamoto, M.; Noda, M.; Morishita, M. 1992: Soluble interleukin 2 receptors in patients with sarcoidosis. Possible origin. Chest 102(4): 1128-1133
Igaz, P.; Tóth, S.; Rose-John, S.; Madurka, I.; Fejér, G.; Szalai, C.; Falus, A. 1998: Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes. Cytokine 10(8): 620-626
Frieling, J.T.; Sauerwein, R.W.; Wijdenes, J.; Hendriks, T.; van der Linden, C.J. 1994: Soluble interleukin 6 receptor in biological fluids from human origin. Cytokine 6(4): 376-381
Mackiewicz, A.; Wiznerowicz, M.; Roeb, E.; Karczewska, A.; Nowak, J.; Heinrich, P.C.; Rose-John, S. 1995: Soluble interleukin 6 receptor is biologically active in vivo. Cytokine 7(2): 142-149
De Rie, M.A.; Zonneveld, I.M.; Witkamp, L.; Van Lier, R.A.; Out, T.A.; Bos, J.D. 1996: Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1. Acta Dermato-Venereologica 76(5): 357-360
Hurteau, J.A.; Woolas, R.P.; Jacobs, I.J.; Oram, D.C.; Kurman, C.C.; Rubin, L.A.; Nelson, D.L.; Berchuck, A.; Bast, R.C.; Mills, G.B. 1995: Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer. Cancer 76(9): 1615-1620
Park, C.S.; Lee, S.M.; Uh, S.T.; Kim, H.T.; Chung, Y.T.; Kim, Y.H.; Choi, B.W.; Hue, S.H.; Lee, H.B. 1993: Soluble interleukin-2 receptor and cellular profiles in bronchoalveolar lavage fluid from patients with bronchial asthma. Journal of Allergy and Clinical Immunology 91(2): 623-633
Shohat, B.; Shohat, M.; Faktor, J.H.; Barkay, G.; Harell, D.; Kozenitzky, L.; Shohat, M. 1993: Soluble interleukin-2 receptor and interleukin-2 in human amniotic fluid of normal and abnormal pregnancies. Biology of the Neonate 63(5): 281-284
Spadaro, A.; Taccari, E.; Sensi, F.; Riccieri, V.; Sili Scavalli, A.; Zoppini, A. 1998: Soluble interleukin-2 receptor and interleukin-6 levels: Evaluation during cyclosporin A and methotrexate treatment in psoriatic arthritis. Clinical Rheumatology 17(1): 83-85
Piccinini, L.; Zironi, S.; Cenci, A.M.; Campioli, D.; Federico, M.; Barbieri, F. 1993: Soluble interleukin-2 receptor and urinary neopterin concentrations in malignant lymphoma. European Journal of Clinical Chemistry and Clinical Biochemistry 31(9): 567-574
Hsu, M.M.; Chen, Y.J.; Chang, Y.L.; Ko, J.Y.; Sheen, T.S. 1995: Soluble interleukin-2 receptor as a clinical parameter for nasopharyngeal carcinoma. Asian Pacific Journal of Allergy and Immunology 13(1): 1-4
Spear, M.L.; Stefano, J.L.; Fawcett, P.; Proujansky, R. 1995: Soluble interleukin-2 receptor as a predictor of neonatal sepsis. Journal of Pediatrics 126(6): 982-985
Louis, E.; Belaiche, J.; Van Kemseke, C.; Schaaf, N.; Mahieu, P.; Mary, J.Y. 1995: Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse. Digestive Diseases and Sciences 40(8): 1750-1756
Bernengo, M.G.; Fierro, M.T.; Novelli, M.; Lisa, F.; Appino, A. 1993: Soluble interleukin-2 receptor in Sézary syndrome: its origin and clinical application. British Journal of Dermatology 128(2): 124-129
Konda, R.; Sakai, K.; Ota, S.; Takeda, A.; Chida, N.; Sato, H.; Orikasa, S. 1998: Soluble interleukin-2 receptor in children with reflux nephropathy. Journal of Urology 159(2): 535-539
Liu, X.P.; An; Huai, L. Jiang; Ying 1995: Soluble interleukin-2 receptor in esophageal carcinoma patients before and after radiotherapy. Zhongguo Zhongliu Linchuang 22(8): 561-563
Ambrosetti, A.; Nadali, G.; Vinante, F.; Ricetti, M.M.; Todeschini, G.; Morosato, L.; de Sabata, D.; Bergamo Andreis, I.A.; Chilosi, M.; Semenzato, G. 1993: Soluble interleukin-2 receptor in hairy-cell leukemia: A reliable marker of disease. International Journal of Clinical and Laboratory Research 23(1): 34-37
Chen, H.S.; Wu, M.S.; Yen, T.S.; Chen, W.Y. 1995: Soluble interleukin-2 receptor in patients with glomerular diseases. Postgraduate Medical Journal 71(840): 617-622
Wen, R.; Xie, S. 1996: Soluble interleukin-2 receptor in patients with urinary bladder cancer. Zhonghua Zhong Liu Za Zhi 18(3): 224-226
Tomás, S.; Coll, J.; Palazón, X. 1997: Soluble interleukin-2 receptor in primary and secondary Sjögren's syndrome. British Journal of Rheumatology 36(2): 194-197
Carotti, M.; Salaffi, F.; Ferraccioli, G.F.; Binci, M.C.; Sartini, A.; Cervini, C. 1994: Soluble interleukin-2 receptor in sera and synovial fluids of rheumatoid patients: Correlations with disease activity. Rheumatology International 14(2): 47-52
Motojima, S.; Ogata, H.; Tateishi, K.; Kushima, A.; Yamai, T.; Fukuda, T.; Makino, S. 1993: Soluble interleukin-2 receptor in sputum from patients with bronchial asthma. Arerugi 42(2): 162-166
Smallridge, R.C.; Tsokos, G.C.; Burman, K.D.; Porter, L.; Cranston, T.; Sfikakis, P.P.; Solomon, B.L. 1997: Soluble interleukin-2 receptor is a thyroid hormone-dependent early-response marker in the treatment of thyrotoxicosis. Clinical and Diagnostic Laboratory Immunology 4(5): 583-586
Laut, J.; Senitzer, D.; Petrucci, R.; Sablay, L.B.; Barland, P.; Glicklich, D. 1992: Soluble interleukin-2 receptor levels in lupus nephritis. Clinical Nephrology 38(4): 179-184
Limas, C.J.; Goldenberg, I.F.; Limas, C. 1995: Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies. Circulation 91(3): 631-634
Tartour, E.; Deneux, L.; Mosseri, V.; Jaulerry, C.; Brunin, F.; Point, D.; Validire, P.; Dubray, B.; Fridman, W.H.; Rodriguez, J. 1997: Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: Results of a Multivariate Prospective Study. Cancer 79(7): 1401-1408
Szeimies, R.M.; Rueff, F.; Kaudewitz, P. 1992: Soluble interleukin-2 receptor serum levels in mycosis fungoides. Correlation with clinical stage. Cancer 70(9): 2338-2341
Akdis, A.C.; Akalin, H.; Mistik, R.; Helvaci, S.; Killicturgay, K. 1995: Soluble interleukin-2 receptor-alpha in cerebrospinal fluid is a differential diagnostic marker for tuberculous meningitis. Immunology and Infectious Diseases 5(2): 138-141
Sarandakou, A.; Poulakis, N.; Rizos, D.; Trakakis, E.; Phocas, I. 1993: Soluble interleukin-2 receptors (sIL-2R) and neuron specific enolase (NSE) in small cell lung carcinoma. Anticancer Research 13(1): 173-175
Hanlon, M.G.; Rogers, M.; Kakakios, A.M.; Isaacs, D.; Mcneil, R.J. 1996: Soluble interleukin-2 receptors in paediatric atopic dermatitis. Immunology and Infectious Diseases 6(3-4): 215-220
Pavlidis, N.; Nicolaides, C.; Bairaktari, E.; Kalef-Ezra, J.; Athanassiadis, A.; Seferiadis, C.; Fountzilas, G. 1996: Soluble interleukin-2 receptors in patients with advanced colorectal carcinoma. International Journal of Biological Markers 11(1): 6-11
Kilpatrick, D.C. 1992: Soluble interleukin-2 receptors in recurrent miscarriage and the effect of leukocyte immunotherapy. Immunology Letters 34(3): 201-206
Bodey, B.; Psenko, V.; Lipsey, A.L.; Kaiser, H.E. 1996: Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms. Anticancer Research 16(1): 219-224
Dalekos, G.N.; Manoussakis, M.N.; Goussia, A.C.; Tsianos, E.V.; Moutsopoulos, H.M. 1993: Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis. Gut 34(5): 658-664
Spadaro, A.; Riccieri, V.; Sili Scavalli, A.; Sensi, F.; Taccari, E.; Zoppini, A. 1996: Soluble interleukin-2-receptor and interleukin-6 changes during low-dose methotrexate treatment in rheumatoid arthritis. Clinical Rheumatology 15(2): 218-219
Blum, C.; Zillikens, D.; Tony, H.P.; Hartmann, A.A.; Burg, G. 1993: Soluble interleukin-2-receptor as activity parameter in serum of patients with systemic and discoid lupus erythematosus. Hautarzt 44(5): 290-295
Weis, M.; Hartmann, A.; Scheuermann, E.H.; Olbrich, H.G. 1998: Soluble interleukin-2-receptor levels as a marker of coronary microvascular dysfunction after heart transplantation. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 17(3): 294-298
Schauer, U.; Schmitt, M.; Müller, S.; Enssle, K.; Kurrle, R.; Sundermann, U.; Bender, A.; Wahn, U.; Rieger, C.H. 1995: Soluble interleukin-4 receptor in atopic children. International Archives of Allergy and Immunology 108(2): 175-182
Ruhl, S.; Pluznik, D.H.; Feldman, G.M. 1993: Soluble interleukin-4 receptor production by murine myeloid progenitor cells: induction by interleukin-6 and interferon-gamma. Cytokine 5(2): 144-149
Banks, M.; Graber, P.; Proudfoot, A.E.; Arod, C.Y.; Allet, B.; Bernard, A.R.; Sebille, E.; McKinnon, M.; Wells, T.N.; Solari, R. 1995: Soluble interleukin-5 receptor alpha-chain binding assays: use for screening and analysis of interleukin-5 mutants. Analytical Biochemistry 230(2): 321-328
Schöbitz, B.; Pezeshki, G.; Pohl, T.; Hemmann, U.; Heinrich, P.C.; Holsboer, F.; Reul, J.M. 1995: Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. FASEB Journal 9(8): 659-664
Matsuzaki, N.; Neki, R.; Sawai, K.; Shimoya, K.; Okada, T.; Sakata, M.; Saji, F.; Koishihara, Y.; Ida, N. 1995: Soluble interleukin-6 (IL-6) receptor in the sera of pregnant women forms a complex with IL-6 and augments human chorionic gonadotropin production by normal human trophoblasts through binding to the IL-6 signal transducer. Journal of Clinical Endocrinology and Metabolism 80(10): 2912-2917
Kyrtsonis, M.C.; Dedoussis, G.; Zervas, C.; Perifanis, V.; Baxevanis, C.; Stamatelou, M.; Maniatis, A. 1996: Soluble interleukin-6 receptor (sIL-6R), a new prognostic factor in multiple myeloma. British Journal of Haematology 93(2): 398-400
Pulkki, K.; Pelliniemi, T.T.; Rajamäki, A.; Tienhaara, A.; Laakso, M.; Lahtinen, R. 1996: Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Finnish Leukaemia Group. British Journal of Haematology 92(2): 370-374
Yokoyama, A.; Kohno, N.; Fujino, S.; Abe, M.; Ishida, O.; Hiwada, K. 1996: Soluble interleukin-6 receptor levels in pleural effusions. Respiratory Medicine 90(6): 329-332
Gabay, C.; Silacci, P.; Genin, B.; Mentha, G.; Le Coultre, C.; Guerne, P.A. 1995: Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes. European Journal of Immunology 25(8): 2378-2383
Tamura, T.; Udagawa, N.; Takahashi, N.; Miyaura, C.; Tanaka, S.; Yamada, Y.; Koishihara, Y.; Ohsugi, Y.; Kumaki, K.; Taga, T. 1993: Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proceedings of the National Academy of Sciences of the United States of America 90(24): 11924-11928
Toren, A.; Novick, D.; Or, R.; Ackerstein, A.; Slavin, S.; Nagler, A. 1996: Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation. Transplantation 62(1): 138-142
Mitsuyama, K.; Toyonaga, A.; Sasaki, E.; Ishida, O.; Ikeda, H.; Tsuruta, O.; Harada, K.; Tateishi, H.; Nishiyama, T.; Tanikawa, K. 1995: Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. Gut 36(1): 45-49
Horiuchi, S.; Koyanagi, Y.; Zhou, Y.; Miyamoto, H.; Tanaka, Y.; Waki, M.; Matsumoto, A.; Yamamoto, M.; Yamamoto, N. 1994: Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. European Journal of Immunology 24(8): 1945-1948
Marquart, M.E.; Picking, W.L.; Picking, W.D. 1996: Soluble invasion plasmid antigen C (IpaC) from Shigella flexneri elicits epithelial cell responses related to pathogen invasion. Infection and Immunity 64(10): 4182-4187
Ruffner, H.-Peter; Huerlimann, M.; Skrivan, R. 1995: Soluble invertase from grape berries: Purification, deglycosylation and antibody specificity. Plant Physiology and Biochemistry (Paris) 33(1): 25-31
Wypych, J.; Bennett, L.G.; Schwartz, M.G.; Clogston, C.L.; Lu, H.S.; Broudy, V.C.; Bartley, T.D.; Parker, V.P.; Langley, K.E. 1995: Soluble kit receptor in human serum. Blood 85(1): 66-73
Oda, Y.; Herrmann, J.; Gitt, M.A.; Turck, C.W.; Burlingame, A.L.; Barondes, S.H.; Leffler, H. 1993: Soluble lactose-binding lectin from rat intestine with two different carbohydrate-binding domains in the same peptide chain. Journal of Biological Chemistry 268(8): 5929-5939
Olson, J.A.; Whitelaw, C.M.; McHardy, K.C.; Pearson, D.W.; Forrester, J.V. 1997: Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia 40(10): 1166-1171
Bufler, P.; Stiegler, G.; Schuchmann, M.; Hess, S.; Krüger, C.; Stelter, F.; Eckerskorn, C.; Schütt, C.; Engelmann, H. 1995: Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants. European Journal of Immunology 25(2): 604-610
Quinn, K.A.; Grimsley, P.G.; Dai, Y.P.; Tapner, M.; Chesterman, C.N.; Owensby, D.A. 1997: Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma. Journal of Biological Chemistry 272(38): 23946-23951
Flavin, M.P.; Coughlin, K.; Ho, L.T. 1997: Soluble macrophage factors trigger apoptosis in cultured hippocampal neurons. Neuroscience 80(2): 437-448
Suzuki, T.; Ohno, N.; Ohshima, Y.; Yadomae, T. 1998: Soluble mannan and beta-glucan inhibit the uptake of Malassezia furfur by human monocytic cell line, THP-1. Fems Immunology and Medical Microbiology 21(3): 223-230
Blann, A.; Seigneur, M. 1997: Soluble markers of endothelial cell function. Clinical Hemorheology and Microcirculation 17(1): 3-11
Monnerie, H.; Boespflug-Tanguy, O.; Dastugue, B.; Meiniel, A. 1996: Soluble material from Reissner's fiber displays anti-aggregative activity in primary cultures of chick cortical neurons. Brain Research. Developmental Brain Research 96(1-2): 120-129
Deniz, G.; Christmas, S.E.; Johnson, P.M. 1996: Soluble mediators and cytokines produced by human CD3- leucocyte clones from decidualized endometrium. Immunology 87(1): 92-98
Noguera, D.R.; Araki, N.; Rittmann, B.E. 1994: Soluble microbial products (SMP) in anaerobic chemostats. Biotechnology and Bioengineering 44(9): 1040-1047
Fang, H., H.P.; Jia, X.-Shan 1998: Soluble microbial products (SMP) of acetotrophic methanogenesis. Bioresource Technology 66(3): 235-239
Mehta, P.; Patel, K.D.; Laue, T.M.; Erickson, H.P.; McEver, R.P. 1997: Soluble monomeric P-selectin containing only the lectin and epidermal growth factor domains binds to P-selectin glycoprotein ligand-1 on leukocytes. Blood 90(6): 2381-2389
Marchot, P.; Ravelli, R.B.; Raves, M.L.; Bourne, Y.; Vellom, D.C.; Kanter, J.; Camp, S.; Sussman, J.L.; Taylor, P. 1996: Soluble monomeric acetylcholinesterase from mouse: expression, purification, and crystallization in complex with fasciculin. Protein Science: a Publication of the Protein Society 5(4): 672-679
Wallny, H.J.; Sollami, G.; Karjalainen, K. 1995: Soluble mouse major histocompatibility complex class Ii molecules produced in Drosophila cells. European Journal of Immunology 25(5): 1262-1266
Levine, H. 1995: Soluble multimeric Alzheimer beta(1-40) pre-amyloid complexes in dilute solution. Neurobiology of Aging 16(5): 755-764
Tang, S.; Woodhall, R.W.; Shen, Y.J.; deBellard, M.E.; Saffell, J.L.; Doherty, P.; Walsh, F.S.; Filbin, M.T. 1997: Soluble myelin-associated glycoprotein (MAG) found in vivo inhibits axonal regeneration. Molecular and Cellular Neurosciences 9(5-6): 333-346
Matsuda, Y.; Okitsu, A.; Sato, S.; Koito, H.; Yamamoto, H. 1996: Soluble myelin-associated glycoprotein-immunoglobulin G1 chimera protein promotes neurite outgrowth from mouse cerebellar neurons. Neuroscience Letters 205(2): 87-90
Macdonald, A.M.; Edwards, A.C.; Pugh, K.B.; Balls, P.W. 1995: Soluble nitrogen and phosphorus in the River Ythan system, U.K.: Annual and seasonal trends. Water Research 29(3): 837-846
Chang, S.I.; Kang, M.K.; Choi, J.D.; Namgoong, S.K. 1997: Soluble overexpression in Escherichia coli, and purification and characterization of wild-type recombinant tobacco acetolactate synthase. Biochemical and Biophysical Research Communications 234(3): 549-553
Toney, J.H.; Hammond, G.G.; Leiting, B.; Pryor, K.D.; Wu, J.K.; Cuca, G.C.; Pompliano, D.L. 1998: Soluble penicillin-binding protein 2a: beta-lactam binding and inhibition by non-beta-lactams using a 96-well format. Analytical Biochemistry 255(1): 113-119
Koppaka, V.; Wang, J.; Banerjee, M.; Lentz, B.R. 1996: Soluble phospholipids enhance factor Xa-catalyzed prothrombin activation in solution. Biochemistry 35(23): 7482-7491
Butler, T.; Rolfe, R.D.; James, G.M.; Hentges, D.J. 1994: Soluble plasma antigen in experimental Salmonella typhimurium infection in mice. FEMS Immunology and Medical Microbiology 9(4): 325-332
Blann, A.D.; Wadley, M.S.; Dobrotova, M.; Sanders, P.; Jayson, M.I.; McCollum, C.N. 1998: Soluble platelet endothelial cell adhesion molecule-1 (sPECAM-1) in inflammatory vascular disease, atherosclerotic vascular disease, and in cancer. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 9(1): 99-103
Sachs, J.R. 1994: Soluble polycations and cationic amphiphiles inhibit volume-sensitive K-Cl cotransport in human red cell ghosts. American Journal of Physiology 266(4 Pt 1): C997-1005
Molteni, V.; Annunziata, R.; Cinquini, M.; Cozzi, F.; Bengalia, M. 1998: Soluble polymer-supported synthesis of imines and beta-lactams. Tetrahedron Letters 39(10): 1257-1260
Bayley, D.; Sancho, M.-Rose; Brown, J.; Brookman, L.; Petrak, K.; Goddard, P.; Steward, A. 1993: Soluble polymeric carriers for drug delivery: Part 6. Preparation and biodistribution of N-5-hydroxyethyl-L-glutamine-co-L-glutamic acid copolymers in rats. Journal of Bioactive and Compatible Polymers 8(1): 51-68
Jakobsen, P.H.; Mckay, V.; N'jie, R.; Olaleye, B.O.; D'alessandro, U.; Bendtzen, K.; Schousboe, I.; Greenwood, B.M. 1996: Soluble products of inflammatory reactions are not induced in children with asymptomatic Plasmodium falciparum infections. Clinical and Experimental Immunology 105(1): 69-73
Mameli, M.; Tuccini, A.; Mazza, M.; Petacchi, R.; Pelosi, P. 1996: Soluble proteins in chemosensory organs of phasmids. Insect Biochemistry and Molecular Biology 26(8-9): 875-882
Rao, T.D.; Frey, A.B. 1998: Soluble proteins isolated from Borrelia burgdorferi by extraction with Triton X-114 confer resistance to experimental infection. Clinical Immunology and Immunopathology 89(1): 94-104
Gautron, J.; Nys, Y. 1995: Soluble proteins of the avian eggshell matrix and of the uterine fluid: Characterisation and involvement in shell mineralisation. Bulletin de l'Institut Oceanographique (Monaco) 1995(SPEC ISSUE 14 Part 2): 151-161
Wahlberg, K.; Høyer-Hansen, G.; Casslén, B. 1998: Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer. Cancer Research 58(15): 3294-3298
Colston, E.; Racaniello, V.R. 1994: Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO Journal 13(24): 5855-5862
Müller-Newen, G.; Köhne, C.; Heinrich, P.C. 1996: Soluble receptors for cytokines and growth factors. International Archives of Allergy and Immunology 111(2): 99-106
Steiner, G.; Studnicka-Benke, A.; Witzmann, G.; Höfler, E.; Smolen, J. 1995: Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis. Journal of Rheumatology 22(3): 406-412
Godfried, M.H.; Romijn, J.A.; van der Poll, T.; Weverling, G.J.; Corssmit, E.P.; Endert, E.; Eeftinck Schattenkerk, J.K.; Sauerwein, H.P. 1995: Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infection. Metabolism, Clinical and Experimental 44(12): 1564-1569
Godfried, M.H.; van der Poll, T.; Weverling, G.J.; Mulder, J.W.; Jansen, J.; van Deventer, S.J.; Sauerwein, H.P. 1994: Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. Journal of Infectious Diseases 169(4): 739-745
Austgulen, R.; Johnsen, H.; Kjøllesdal, A.M.; Liabakk, N.B.; Espevik, T. 1993: Soluble receptors for tumor necrosis factor: occurrence in association with normal delivery at term. Obstetrics and Gynecology 82(3): 343-347
Diez-Ruiz, A.; Tilz, G.P.; Zangerle, R.; Baier-Bitterlich, G.; Wachter, H.; Fuchs, D. 1995: Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. European Journal of Haematology 54(1): 1-8
Godfried, M.H.; van der Poll, T.; Jansen, J.; Romijin, J.A.; Schattenkerk, J.K.; Endert, E.; van Deventer, S.J.; Sauerwein, H.P. 1993: Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. Aids 7(1): 33-36
Arck, P.C.; Troutt, A.B.; Clark, D.A. 1997: Soluble receptors neutralizing TNF-alpha and IL-1 block stress-triggered murine abortion. American Journal of Reproductive Immunology 37(3): 262-266
Piddlesden, S.J.; Storch, M.K.; Hibbs, M.; Freeman, A.M.; Lassmann, H.; Morgan, B.P. 1994: Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. Journal of Immunology 152(11): 5477-5484
Ohno, N.; Ichikawa, H.; Coe, L.; Kvietys, P.R.; Granger, D.N.; Alexander, J.S. 1997: Soluble selectins and ICAM-1 modulate neutrophil-endothelial adhesion and diapedesis in vitro. Inflammation 21(3): 313-324
Pinxteren, J.; Jimenez del Rio, M.; Velez Pardo, C.; Ebinger, G.; Vauquelin, G.; De Potter, W. 1993: Soluble serotonin and catecholamine binding proteins in the bovine adrenal medulla. Neurochemistry International 23(4): 343-350
Steen, V.D.; Engel, E.E.; Charley, M.R.; Medsger, T.A. 1996: Soluble serum interleukin 2 receptors in patients with systemic sclerosis. Journal of Rheumatology 23(4): 646-649
Koumantakis, E.; Matalliotakis, I.; Neonaki, M.; Froudarakis, G.; Georgoulias, V. 1994: Soluble serum interleukin-2 receptor, interleukin-6 and interleukin-1a in patients with endometriosis and in controls. Archives of Gynecology and Obstetrics 255(3): 107-112
Langley, K.E.; Bennett, L.G.; Wypych, J.; Yancik, S.A.; Liu, X.D.; Westcott, K.R.; Chang, D.G.; Smith, K.A.; Zsebo, K.M. 1993: Soluble stem cell factor in human serum. Blood 81(3): 656-660
Yang, X.-Quan; Jiang-Xiao-Cheng; Fu-Jia-Rui 1998: Soluble sugar and the acquisition of desiccation tolerance in peanut (Arachis hypogaea) seeds. Acta Phytophysiologica Sinica 24(2): 165-170
Fromard, L.; Bonnemain, J.L.; Gaudillere, J.P.; Lapierre, C. 1993: Soluble sugars and qualitative analysis of the Acer platanoides xylem sap. Acta Botanica Gallica 140(4): 427-433
Alves, V.M.ria Carvalho; Novais, R.F.rreira De; Oliveira, M.F.avio Godoy De; Mosquim, P.R.berto 1995: Soluble sugars in four maize hybrids under phosphorus deprivation and phosphorus feeding. Revista Brasileira de Fisiologia Vegetal 7(1): 97-105
Lehner, P.J.; Surman, M.J.; Cresswell, P. 1998: Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220. Immunity 8(2): 221-231
Fujieda, M.; Oishi, N.; Naruse, K.; Hashizume, M.; Nishiya, K.; Kurashige, T.; Ito, K. 1998: Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schönlein purpura. Archives of Disease in Childhood 78(3): 240-244
Ohlin, A.K.; Morser, J.; Ohlin, H. 1996: Soluble thrombomodulin antigen in plasma is increased in patients with acute myocardial infarction treated with thrombolytic therapy. Thrombosis Research 82(4): 313-322
Gando, S.; Nakanishi, Y.; Kameue, T.; Nanzaki, S. 1995: Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: role of neutrophil elastase. Journal of Trauma 39(4): 660-664
Takahashi, Y.; Hosaka, Y.; Niina, H.; Nagasawa, K.; Naotsuka, M.; Sakai, K.; Uemura, A. 1995: Soluble thrombomodulin purified from human urine exhibits a potent anticoagulant effect in vitro and in vivo. Thrombosis and Haemostasis 73(5): 805-811
Ku, H.; Hirayama, F.; Kato, T.; Miyazaki, H.; Aritomi, M.; Ota, Y.; D'Andrea, A.D.; Lyman, S.D.; Ogawa, M. 1996: Soluble thrombopoietin receptor (Mpl) and granulocyte colony-stimulating factor receptor directly stimulate proliferation of primitive hematopoietic progenitors of mice in synergy with steel factor or the ligand for Flt3/Flk2. Blood 88(11): 4124-4131
Snyder Conn, E.; Garbarino, J.R.; Hoffman, G.L.; Oelkers, A. 1997: Soluble trace elements and total mercury in arctic Alaskan snow. Arctic 50(3): 201-215
Mcbride, M.B. 1998: Soluble trace metals in alkaline stabilized sludge products. Journal of Environmental Quality 27(3): 578-584
Centis, F.; Delfini, C.; Agostinelli, F.; Tonucci, P.; Gaziev, J.; Annibali, M.; Lucarelli, G. 1994: Soluble transferrin receptor following bone marrow transplantation from donors heterozygous for beta thalassemia. Haematologica 79(5): 448-451
Carpani, G.; Buscaglia, M.; Ghisoni, L.; Pizzotti, D.; Vozzo, N.; Bellotti, M.; Moroni, G. 1996: Soluble transferrin receptor in the study of fetal erythropoietic activity. American Journal of Hematology 52(3): 192-196
Hikawa, A.; Nomata, Y.; Suzuki, T.; Ozasa, H.; Yamada, O. 1996: Soluble transferrin receptor-transferrin complex in serum: Measurement by latex agglutination nephelometric immunoassay. Clinica Chimica Acta; International Journal of Clinical Chemistry 254(2): 159-172
Chesnutt, A.N.; Kheradmand, F.; Folkesson, H.G.; Alberts, M.; Matthay, M.A. 1997: Soluble transforming growth factor-alpha is present in the pulmonary edema fluid of patients with acute lung injury. Chest 111(3): 652-656
Dreher, K.L.; Jaskot, R.H.; Lehmann, J.R.; Richards, J.H.; McGee, J.K.; Ghio, A.J.; Costa, D.L. 1997: Soluble transition metals mediate residual oil fly ash induced acute lung injury. Journal of Toxicology and Environmental Health 50(3): 285-305
Chen-Yuxian, S.-Wei; Wan-Yunxia 1995: Soluble tumor antigens and anti-CD3' McAb costimulated tumor killer cells - T-AK cells. Zhonghua Weishengwuxue He Mianyixue Zazhi 15(5): 293-296
Mohler, K.M.; Torrance, D.S.; Smith, C.A.; Goodwin, R.G.; Stremler, K.E.; Fung, V.P.; Madani, H.; Widmer, M.B. 1993: Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. Journal of Immunology 151(3): 1548-1561
Belldegrun, A.; Pierce, W.; Sayah, D.; deKernion, J.; Wallach, D.; Aderka, D.; Figlin, R.A. 1993: Soluble tumor necrosis factor receptor expression in patients with metastatic renal cell carcinoma treated with interleukin-2-based immunotherapy. Journal of ImmunoTherapy with Emphasis on Tumor Immunology: Official Journal of the Society for Biological Therapy 13(3): 175-180
Arntzen, K.J.; Liabakk, N.B.; Jacobsen, G.; Espevik, T.; Austgulen, R. 1995: Soluble tumor necrosis factor receptor in serum and urine throughout normal pregnancy and at delivery. American Journal of Reproductive Immunology 34(3): 163-169
Lee, C.S.; Chen, K.H.; Wang, P.C. 1997: Soluble tumor necrosis factor receptor in serum of patients with arthritis. Journal of the Formosan Medical Association 96(8): 573-578
Becher, B.; Dodelet, V.; Fedorowicz, V.; Antel, J.P. 1996: Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. Journal of Clinical Investigation 98(7): 1539-1543
Howard, O.M.; Clouse, K.A.; Smith, C.; Goodwin, R.G.; Farrar, W.L. 1993: Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation. Proceedings of the National Academy of Sciences of the United States of America 90(6): 2335-2339
Onsrud, M.; Shabana, A.; Austgulen, R. 1996: Soluble tumor necrosis factor receptors and CA 125 in serum as markers for epithelial ovarian cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 17(2): 90-96
Opsjøn, S.L.; Novick, D.; Wathen, N.C.; Cope, A.P.; Wallach, D.; Aderka, D. 1995: Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnancies. Journal of Reproductive Immunology 29(2): 119-134
Nozaki, N.; Yamaguchi, S.; Shirakabe, M.; Nakamura, H.; Tomoike, H. 1997: Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure. Japanese Circulation Journal 61(8): 657-664
Sippy, B.D.; Hofman, F.M.; Wright, A.D.; He, S.; Ryan, S.J.; Hinton, D.R. 1996: Soluble tumor necrosis factor receptors are present in human vitreous and shed by retinal pigment epithelial cells. Experimental Eye Research 63(3): 311-317
Godfried, M.H.; van der Poll, T.; Mulder, J.W.; Weverling, G.J.; Endert, E.; Lange, J.M.; Sauerwein, H.P. 1995: Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 10(5): 531-539
Kern, P.; Hemmer, C.J.; Gallati, H.; Neifer, S.; Kremsner, P.; Dietrich, M.; Porzsolt, F. 1992: Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. Journal of Infectious Diseases 166(4): 930-934
Kern, W.V.; Engel, A.; Kern, P. 1995: Soluble tumor necrosis factor receptors in febrile neutropenic cancer patients. Infection 23(1): 64-65
Roux-Lombard, P.; Punzi, L.; Hasler, F.; Bas, S.; Todesco, S.; Gallati, H.; Guerne, P.A.; Dayer, J.M. 1993: Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. Arthritis and Rheumatism 36(4): 485-489
Kupferminc, M.J.; Peaceman, A.M.; Aderka, D.; Wallach, D.; Peyser, M.R.; Lessing, J.B.; Socol, M.L. 1995: Soluble tumor necrosis factor receptors in maternal plasma and second-trimester amniotic fluid. American Journal of Obstetrics and Gynecology 173(3 Pt 1): 900-905
Granowitz, E.V.; Saget, B.M.; Angel, J.B.; Wang, M.Z.; Wang, A.; Dinarello, C.A.; Skolnik, P.R. 1996: Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 11(5): 430-437
Sorkine, P.; Setton, A.; Halpern, P.; Miller, A.; Rudick, V.; Marmor, S.; Klausner, J.M.; Goldman, G. 1995: Soluble tumor necrosis factor receptors reduce bowel ischemia-induced lung permeability and neutrophil sequestration. Critical Care Medicine 23(8): 1377-1381
De Benedetti, F.; Pignatti, P.; Massa, M.; Sartirana, P.; Ravelli, A.; Cassani, G.; Corti, A.; Martini, A. 1997: Soluble tumour necrosis factor receptor levels reflect coagulation abnormalities in systemic juvenile chronic arthritis. British Journal of Rheumatology 36(5): 581-588
Vossen, A.C.; Tibbe, G.J.; Buurman, W.A.; Benner, R.; Savelkoul, H.F. 1996: Soluble tumour necrosis factor receptor release after anti-CD3 monoclonal antibody treatment in mice is independent of tumour necrosis factor-alpha release. European Cytokine Network 7(4): 751-755
Hadziselimovic, F.; Emmons, L.R.; Gallati, H. 1995: Soluble tumour necrosis factor receptors p55 and p75 in the urine monitor disease activity and the efficacy of treatment of inflammatory bowel disease. Gut 37(2): 260-263
Steinshamn, S.; Brekke, O.L.; Waage, A. 1995: Soluble tumour necrosis factor receptors, tumour necrosis factor and interleukin-6 in serum in granulocytopenic patients with fever. British Journal of Haematology 89(4): 719-724
Lau, H.K.; Kim, M. 1994: Soluble urokinase receptor from fibrosarcoma HT-1080 cells. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 5(4): 473-478
Christiansen, I.; Sundström, C.; Enblad, G.; Tötterman, T.H. 1998: Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease. British Journal of Haematology 102(3): 701-709
Bannan, S.; Mansfield, M.W.; Grant, P.J. 1998: Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia 41(4): 460-466
De Caterina, R.; Basta, G.; Lazzerini, G.; Dell'Omo, G.; Petrucci, R.; Morale, M.; Carmassi, F.; Pedrinelli, R. 1997: Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology 17(11): 2646-2654
Willsie, S.K.; Herndon, B.L.; Miller, L.; Dew, M. 1996: Soluble versus cell-bound CD4, CD8 from bronchoalveolar lavage: correlation with pulmonary diagnoses in human immunodeficiency virus-infected individuals. Journal of Leukocyte Biology 59(6): 813-816
Zamorano, J.; Rivas, D.; Gayo, A.; Mozo, L.; Gutiérrez, C. 1995: Soluble, but not immobilized, anti-IgM antibody inhibits post-activation events leading to T-cell-dependent B-cell differentiation. Immunology 85(2): 241-247
Wolf, G.A.; Wirth, S.J. 1996: Soluble, dye-labelled substrates for a micro-plate assay of proteinase activity. Journal of Microbiological Methods 25(3): 337-342
Markussen, J.; Havelund, S.; Kurtzhals, P.; Andersen, A.S.; Halstrøm, J.; Hasselager, E.; Larsen, U.D.; Ribel, U.; Schäffer, L.; Vad, K.; Jonassen, I. 1996: Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs. Diabetologia 39(3): 281-288
Jadot, M.; Wattiaux, R.; Mainferme, F.; Dubois, F.; Claessens, A.; Wattiaux-De Coninck, S. 1996: Soluble form of Lamp Ii in purified rat liver lysosomes. Biochemical and Biophysical Research Communications 223(2): 353-359
Lee, J.; Jiao, X.; Gentleman, S.; Wetzel, M.G.; O'Brien, P.; Chader, G.J. 1995: Soluble-binding proteins for docosahexaenoic acid are present in neural retina. IOVS Investigative Ophthalmology and Visual Science 36(10): 2032-2039
Venter, C.S.; Nel, C.J.; Vorster, H.H.; Jerling, J.C.; Oosthuizen, W.; Veldman, F.J.; Kellerman, J.A.; Smuts, C.M.; Vermaak, W.J.; van der Nest, D.G.; de Ridder, J.H. 1997: Soluble-fibre concentrate lowers plasminogen activator inhibitor-1 in baboons (Papio ursinus). British Journal of Nutrition 78(4): 625-637
Byron, P.R.; Sun, Z.; Katayama, H.; Rypacek, F. 1994: Solute absorption from the airways of the isolated rat lung. IV. Mechanisms of absorption of fluorophore-labeled poly-alpha,beta-[N(2-hydroxyethyl)-DL-aspartamide. Pharmaceutical Research 11(2): 221-225
Vogelien, D.L.; Hickok, L.G.; Auge, R.M.; Stodola, A.J.W.; Hendrix, D. 1993: Solute analysis and water relations of gametophyte mutants tolerant to NaCl in the fern Ceratopteris richardii. Plant Cell and Environment 16(8): 959-966
Mirecki, J.E.; Campbell, B.G.; Conlon, K.J.; Petkewich, M.D. 1998: Solute changes during aquifer storage recovery testing in a limestone/clastic aquifer. Ground Water 36(3): 394-403
Ohno, A.; Müller, E.; Fraek, M.L.; Thurau, K.; Beck, F. 1997: Solute composition and heat shock proteins in rat renal medulla. Pflugers Archiv: European Journal of Physiology 434(1): 117-122
Bassolino-Klimas, D.; Alper, H.E.; Stouch, T.R. 1993: Solute diffusion in lipid bilayer membranes: An atomic level study by molecular dynamics simulation. Biochemistry 32(47): 12624-12637
Kelsey Tracey, L.J.; Langsdorf, L.J.; Zydney, A.L. 1994: Solute diffusion through porous membranes and its application to membrane bioreactors. Bioseparation 4(3): 165-174
Abraham, M., H.; Poole, C., F.; Poole, S., K. 1996: Solute effects on reversed-phase thin-layer chromatography: A linear free energy relationship analysis. Journal of Chromatography A 749(1-2): 201-209
Vierl, U.; Löbbecke, L.; Nagel, N.; Cevc, G. 1994: Solute effects on the colloidal and phase behavior of lipid bilayer membranes: ethanol-dipalmitoylphosphatidylcholine mixtures. Biophysical Journal 67(3): 1067-1079
Webster, I.T.; Norquay, S.J.; Ross, F.C.; Wooding, R.A. 1996: Solute exchange by convection within estuarine sediments. Estuarine Coastal and Shelf Science 42(2): 171-183
Zhou, Y.; Hall, C., K. 1996: Solute excluded-volume effects on the stability of globular proteins: A statistical thermodynamic theory. Biopolymers 38(2): 273-284
Muntada, V.; Gerschenson, L.N.; Alzamora, S.M.; Castro, M.A. 1998: Solute infusion effects on texture of minimally processed kiwifruit. Journal of Food Science 63(4): 616-620
Debrunner, N.; Feller, U. 1994: Solute leakage from detached plant parts of winter wheat: Influence of maturation stage and incubation temperature. Journal of Plant Physiology 145(3): 257-260
Celikel, F.G.; Van Doorn, W.G. 1995: Solute leakage, lipid peroxidation, and protein degradation during the senescence of Iris tepals. Physiologia Plantarum 94(3): 515-521
Lencki, R.W.; Neufeld, R.J. 1996: Solute modulation of urease inactivation kinetics. Enzyme and Microbial Technology 19(3): 232-237
Yoshida, N.H.; Roberts, M.S. 1993: Solute molecular size and transdermal iontophoresis across excised human skin. Journal of Controlled Release 25(3): 177-195
Williams, J.P.; Vepraskas, M.J. 1994: Solute movement through quartz-diorite saprolite containing quartz veins and biological macropores. Journal of Environmental Quality 23(4): 810-815
Huettel, M.; Gust, G. 1992: Solute release mechanisms from confined sediment cores in stirred benthic chambers and flume flows. Marine Ecology Progress Series 82(2): 187-197
Wang, H.; Desilets, C.; Regnier, F.E. 1992: Solute retention mechanism in semipermeable surface chromatography. Analytical Chemistry 64(22): 2821-2825
Staby, A.; Mollerup, J. 1996: Solute retention of lysozyme in hydrophobic interaction perfusion chromatography. Journal of Chromatography A 734(1): 205-212
Urban, N., R.; Dinkel, C.; Wehrli, B. 1997: Solute transfer across the sediment surface of a eutrophic lake: I. Porewater profiles from dialysis samplers. Aquatic Sciences 59(1): 1-25
Konings, W.N.; Poolman, B.; Van Veen, H.W. 1994: Solute transport and energy transduction in bacteria. Antonie van Leeuwenhoek 65(4): 369-380
Koch, S.; Fluhler, H. 1993: Solute transport in aggregated porous media: Comparing model independent and dependent parameter estimation. Water Air and Soil Pollution 68(1-2): 275-289
Moreno, L.; Gylling, B.; Neretnieks, I. 1997: Solute transport in fractured media- the important mechanisms for performance assessment. Journal of Contaminant Hydrology 25(3-4): 283-298
Chaphalkar, P.G.; Boy, D. 1994: Solute transport in packed sand columns by colloidal gas aphrons: Experimental evidence and modeling approach. Journal of Environmental Systems 23(1): 51-66
Wang, X.; Matisoff, G. 1997: Solute transport in sediments by a large freshwater oligochaete, Branchiura sowerbyi. Environmental Science and Technology 31(7): 1926-1933
Zhang, R.; Yang, J.; Ye, Z. 1996: Solute transport through the vadose zone: A field study and stochastic analyses. Soil Science 161(5): 270-277
Boyd, R.F.; López, M.; Stephens, C.L.; Vélez, G.M.; Ramírez, C.A.; Zydney, A.L. 1998: Solute washout experiments for characterizing mass transport in hollow fiber immunoisolation membranes. Annals of Biomedical Engineering 26(4): 618-626
Perkins, W.R.; Li, X.; Slater, J.L.; Harmon, P.A.; Ahl, P.L.; Minchey, S.R.; Gruner, S.M.; Janoff, A.S. 1997: Solute-induced shift of phase transition temperature in Di-saturated PC liposomes: Adoption of ripple phase creates osmotic stress. Biochimica et Biophysica Acta 1327(1): 41-51
Hoopman, T.; Birch, G.; Serghat, S.; Portmann, M.-Odile; Mathlouthi, M. 1993: Solute-solvent interactions and the sweet taste of small carbohydrates: Part II. Sweetness intensity and persistence in ethanol-water mixtures. Food Chemistry 46(2): 147-153
Bazylak, G. 1992: Solute-solvent interactions of aliphatic aminoalcohols in underivatized silica-binary eluent HPTLC systems. Journal of Planar Chromatography - Modern TLC 5(4): 239-245
Zimmerman, R.J.; Chao, H.; Fullerton, G.D.; Cameron, I.L. 1993: Solute/solvent interaction corrections account for non-ideal freezing point depression. Journal of Biochemical and Biophysical Methods 26(1): 61-70
Lemmich, J.; Honger, T.; Mortensen, K.; Ipsen, J.-Hjort; Bauer, R.; Mouritsen, O., G. 1996: Solutes in small amounts provide for lipid-bilayer softness: Cholesterol, short-chain lipids, and bola lipids. European Biophysics Journal 25(1): 61-65
Teng, Q.; Zhou, Z.H.; Smith, E.T.; Busse, S.C.; Howard, J.B.; Adams, M.W.; La Mar, G.N. 1994: Solution 1H NMR determination of secondary structure for the three-iron form of ferredoxin from the hyperthermophilic archaeon Pyrococcus furiosus. Biochemistry 33(20): 6316-6326
Zhang, W.; La Mar, G.N.; Gersonde, K. 1996: Solution 1H-NMR structure of the heme cavity in the low-affinity state for the allosteric monomeric cyano-met hemoglobins from Chironomus thummi thummi. Comparison to the crystal structure. European Journal of Biochemistry 237(3): 841-853
Abuaf, P.; Hingerty, B.E.; Broyde, S.; Grunberger, D. 1995: Solution Conformation of the N-(Deoxyguanosin-8-yl)aminofluorene Adduct opposite Deoxyinosine and Deoxyguanosine in DNA by NMR and Computational Characterization. Chemical Research in Toxicology 8(3): 369-378
Buolamwini, J., K.; Barchi, J., J.,. Jr.; 1997: Solution NMR conformational analysis of the potent equilibrative sensitive (ES) nucleoside transporter inhibitor, S6-(4-nitrobenzyl)mercaptopurine riboside (NBMPR). Nucleosides and Nucleotides 16(12): 2101-2110
Osapay, K.; Theriault, Y.; Wright, P.E.; Case, D.A. 1994: Solution structure of carbonmonoxy myoglobin determined from nuclear magnetic resonance distance and chemical shift constraints. Journal of Molecular Biology 244(2): 183-197
Kim, K.S.; Clark-Lewis, I.; Sykes, B.D. 1994: Solution structure of GRO/melanoma growth stimulatory activity determined by 1H NMR spectroscopy. Journal of Biological Chemistry 269(52): 32909-32915
Mer, G.; Kellenberger, C.; Koehl, P.; Stote, R.; Sorokine, O.; Van Dorsselaer, A.; Luu, B.; Hietter, H.; Lefèvre, J.F. 1994: Solution Structure of PMP-D2, a 35-Residue Peptide Isolated from the Insect Locusta migratoria. Biochemistry 33(51): 15397-15407
Fréchet, D.; Guitton, J.D.; Herman, F.; Faucher, D.; Helynck, G.; Monegier du Sorbier, B.; Ridoux, J.P.; James-Surcouf, E.; Vuilhorgne, M. 1994: Solution Structure of RP 71955, a New 21 Amino Acid Tricyclic Peptide Active against HIV-1 Virus. Biochemistry 33(1): 42-50
Andreu, J.M.; Díaz, J.F.; Gil, R.; de Pereda, J.M.; García de Lacoba, M.; Peyrot, V.; Briand, C.; Towns-Andrews, E.; Bordas, J. 1994: Solution structure of Taxotere-induced microtubules to 3-nm resolution. The change in protofilament number is linked to the binding of the taxol side chain. Journal of Biological Chemistry 269(50): 31785-31792
Chen, H.; Patel, D.J. 1995: Solution structure of a quinomycin bisintercalator-DNA complex. Journal of Molecular Biology 246(1): 164-179
Boulard, Y.; Cognet, J.A.; Gabarro-Arpa, J.; Le Bret, M.; Carbonnaux, C.; Fazakerley, G.V. 1995: Solution structure of an oncogenic DNA duplex, the K-ras gene and the sequence containing a central C.A or A.G mismatch as a function of pH: nuclear magnetic resonance and molecular dynamics studies. Journal of Molecular Biology 246(1): 194-208
Weisz, K.; Shafer, R.H.; Egan, W.; James, T.L. 1994: Solution Structure of the Octamer Motif in Immunoglobulin Genes via Restrained Molecular Dynamics Calculations. Biochemistry 33(1): 354-366
Konno, T.; Kataoka, M.; Kamatari, Y.; Kanaori, K.; Nosaka, A.; Akasaka, K. 1995: Solution X-ray scattering analysis of cold- heat-, and urea-denatured states in a protein, Streptomyces subtilisin inhibitor. Journal of Molecular Biology 251(1): 95-103
Yoshino, H.; Izumi, Y.; Sakai, K.; Takezawa, H.; Matsuura, I.; Maekawa, H.; Yazawa, M. 1996: Solution X-ray scattering data show structural differences between yeast and vertebrate calmodulin: implications for structure/function. Biochemistry 35(7): 2388-2393
Sano, Y.; Inoue, H.; Hiragi, Y.; Urakawa, H.; Kajiwara, K. 1995: Solution X-ray scattering study of reconstitution process of tobacco mosaic virus particle using low-temperature quenching. Biophysical Chemistry 55(3): 239-245
Igarashi, Y.; Kimura, K.; Ichimura, K.; Matsuzaki, S.; Ikura, T.; Kuwajima, K.; Kihara, H. 1995: Solution X-ray scattering study on the chaperonin GroEL from Escherichia coli. Biophysical Chemistry 53(3): 259-266
Nguyen, B.D.; Zhao, X.; Vyas, K.; La Mar, G.N.; Lile, R.A.; Brucker, E.A.; Phillips, G.N.; Olson, J.S.; Wittenberg, J.B. 1998: Solution and crystal structures of a sperm whale myoglobin triple mutant that mimics the sulfide-binding hemoglobin from Lucina pectinata. Journal of Biological Chemistry 273(16): 9517-9526
Bozzi, L.; Milas, M.; Rinaudo, M. 1996: Solution and gel rheology of a new polysaccharide excreted by the bacterium Alteromonas sp. strain 1644. International Journal of Biological Macromolecules 18(1-2): 83-91
Wertz, S.L.; Savino, Y.; Cafiso, D.S. 1996: Solution and membrane bound structure of a peptide derived from the protein kinase C substrate domain of neuromodulin. Biochemistry 35(34): 11104-11112
Leusch, A.H.lan, Z.; Volesky, B. 1996: Solution and particle effects on the biosorption of heavy metals by seaweed biomass. Applied biochemistry and biotechnology 61(3): 231-249
Hjortso, M. 1995: Solution and properties of age population balance models which assume discrete division ages. Journal of Biotechnology 42(3): 271-280
Rigby, A.C.; Grant, C.W.; Shaw, G.S. 1998: Solution and solid state conformation of the human EGF receptor transmembrane region. Biochimica et Biophysica Acta 1371(2): 241-253
Agback, P.; Papchikhin, A.; Neidle, S.; Chattopadhyaya, J. 1993: Solution and solid state structure of 2',5'-bis-(O-trityl)-3'-oximinouridine. Nucleosides and Nucleotides 12(6): 605-614
Rossi, F.; Saviano, M.; Di Talia, P.; Di Blasio, B.; Pedone, C.; Zanotti, G.; Mosca, M.; Saviano, G.; Tancredi, T.; Ziegler, K.; Benedetti, E. 1996: Solution and solid state structure of an aib-containing cyclodecapeptide inhibiting the cholate uptake in hepatocytes. Biopolymers 40(5): 465-478
Gonzalez, M.; Loomis, P.M.; Loomis, R.E. 1993: Solution and solid-state circular dichroism analyses of a human salivary proline-rich glycoprotein repeating domain and its subfragments. International Journal of Biological Macromolecules 15(3): 153-167
Ciajolo, M.R.; Balboni, G.; Picone, D.; Salvadori, S.; Tancredi, T.; Temussi, P.A.; Tuzi, A. 1995: Solution and solid-state structure of the diketopiperazine of tyrosyl-tetrahydroisoquinoline-3-carboxylic acid. International Journal of Peptide and Protein Research 46(2): 134-138
Wu, Z.; Johnson, K.W.; Goldstein, B.; Choi, Y.; Eaton, S.F.; Laue, T.M.; Ciardelli, T.L. 1995: Solution assembly of a soluble, heteromeric, high affinity interleukin-2 receptor complex. Journal of Biological Chemistry 270(27): 16039-16044
Meyer, J.D.; Matsuura, J.E.; Kendrick, B.S.; Evans, E.S.; Evans, G.J.; Manning, M.C. 1995: Solution behavior of alpha-chymotrypsin dissolved in nonpolar organic solvents via hydrophobic ion pairing. Biopolymers 35(5): 451-456
Powers, Michael E.; Adjei, Akwete; Fu Lu, Mou Ying; Manning, Mark C. 1994: Solution behavior of leuprolide acetate, an LHRH agonist, as determined by circular dichroism spectroscopy. International Journal of Pharmaceutics (Amsterdam) 108(1): 49-55
Veitch, N.C.; Williams, R.J.; Bone, N.M.; Burke, J.F.; Smith, A.T. 1995: Solution characterisation by NMR spectroscopy of two horseradish peroxidase isoenzyme C mutants with alanine replacing either Phe142 or Phe143. European Journal of Biochemistry 233(2): 650-658
Wang, Q.; Ellis, P.R.; Ross Murphy, S.B.; Burchard, W. 1997: Solution characteristics of the xyloglucan extracted from Detarium senegalense Gmelin. Carbohydrate Polymers 33(2): 115-124
Poveda, A.; Asensio, J.L.; Martín-Pastor, M.; Jiménez-Barbero, J. 1997: Solution conformation and dynamics of a tetrasaccharide related to the Lewix(X) antigen deduced by 1H NMR NOESY, ROESY, and T-ROESY measurements. Carbohydrate Research 300(1): 3-10
Poveda, A.; Asensio, J.L.; Martín-Pastor, M.; Jiménez-Barbero, J. 1997: Solution conformation and dynamics of a tetrasaccharide related to the Lewis(x) antigen deduced by NMR relaxation measurements. Journal of Biomolecular NMR 10(1): 29-43
Hennig, P.; Raimbaud, E.; Thurieau, C.; Volland, J.P.; Michel, A.; Fauchère, J.L. 1996: Solution conformation by NMR and molecular modeling of three sulfide-free somatostatin octapeptide analogs compared to angiopeptin. Journal of Computer-Aided Molecular Design 10(1): 83-86
Moroder, L.; D'ursi, A.; Picone, D.; Amodeo, P.; Temussi, P.A. 1993: Solution conformation of CCK9, a cholecystokinin analog. Biochemical and Biophysical Research Communications 190(3): 741-746
Stevenson, C.L.; Donlan, M.E.; Friedman, A.R.; Borchardt, R.T. 1993: Solution conformation of Leu27 hGRF(1-32)NH2 and its deamidation products by 2D NMR. International Journal of Peptide and Protein Research 42(1): 24-32
Kurutz, J.W.; Kiessling, L.L. 1997: Solution conformation of Lewis a--derived selectin ligands is unaffected by anionic substituents at the 3'- and 6'-positions. Glycobiology 7(3): 337-347
Thompson, A.S.; Hurley, L.H. 1995: Solution conformation of a bizelesin A-tract duplex adduct: DNA-DNA cross-linking of an A-tract straightens out bent DNA. Journal of Molecular Biology 252(1): 86-101
Zhang, M.; Quinn, T.P.; Wong, T.C. 1994: Solution conformation of a cyclic neurokinin antagonist: a NMR and molecular dynamics study. Biopolymers 34(9): 1165-1173
Kakalis, L.T.; Armitage, I.M. 1994: Solution conformation of a cyclophilin-bound proline isomerase substrate. Biochemistry 33(6): 1495-1501
Luebke, K.J.; Landry, S.M.; Tinoco, I. 1997: Solution conformation of a five-nucleotide RNA bulge loop from a group i intron. Biochemistry 36(33): 10246-10255
Di Nola, A.; Fabrizi, G.; Lamba, D.; Segre, A.L. 1994: Solution conformation of a pectic acid fragment by 1H-NMR and molecular dynamics. Biopolymers 34(4): 457-462
Cros, S.; du Penhoat, C.H.; Bouchemal, N.; Ohassan, H.; Imberty, A.; Pérez, S. 1992: Solution conformation of a pectin fragment disaccharide using molecular modelling and nuclear magnetic resonance. International Journal of Biological Macromolecules 14(6): 313-320
Plowman, J.E.; Creamer, L.K.; Liddell, M.J.; Cross, J.J. 1997: Solution conformation of a peptide corresponding to bovine kappa-casein B residues 130-153 by circular dichroism spectroscopy and 1H-nuclear magnetic resonance spectroscopy. Journal of Dairy Research 64(3): 377-397
Cheng, J.W.; Cheng, C.C.; Lyu, P.C.; Chen, S.T.; Lin, T.H. 1996: Solution conformation of a peptide corresponding to residues 151-172 of HIV-1 integrase using NMR and CD spectroscopy. International Journal of Peptide and Protein Research 47(1-2): 117-122
Chiche, L.; Heitz, A.; Padilla, A.; Le-Nguyen, D.; Castro, B. 1993: Solution conformation of a synthetic bis-headed inhibitor of trypsin and carboxypeptidase A: new structural alignment between the squash inhibitors and the potato carboxypeptidase inhibitor. Protein Engineering 6(7): 675-682
Larue, V.; Gharbi-Benarous, J.; Acher, F.; Arulmozhi, V.; Tisné, C.; Todeschi, N.; Azerad, R.; Girault, J.P. 1997: Solution conformation of alpha, beta or gamma-methylglutamyl-containing derivatives as probes of vitamin K-dependent carboxylase using molecular modelling and nuclear magnetic resonance. International Journal of Biological Macromolecules 20(2): 131-159
Fairbrother, W.J.; Mcdowell, R.S.; Cunningham, B.C. 1994: Solution conformation of an atrial natriuretic peptide variant selective for the type A receptor. Biochemistry 33(30): 8897-8904
Bartley, J.P.; Brown, T.; Lane, A.N. 1997: Solution conformation of an intramolecular DNA triplex containing a nonnucleotide linker: comparison with the DNA duplex. Biochemistry 36(47): 14502-14511
Gervais, V.; Guy, A.; Téoule, R.; Fazakerley, G.V. 1992: Solution conformation of an oligonucleotide containing a urea deoxyribose residue in front of a thymine. Nucleic Acids Research 20(24): 6455-6460
Le Breton, E.R.; Carver, J.A. 1996: Solution conformation of bovine lens alpha- and betaB2-crystallin terminal extensions. International Journal of Peptide and Protein Research 47(1-2): 9-19
Yu, C.; Bhaskaran, R.; Chuang, L.C.; Yang, C.C. 1993: Solution conformation of cobrotoxin: A nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study. Biochemistry 32(9): 2131-2136
Cai, M.; Timkovich, R. 1994: Solution conformation of cytochrome c-551 from Pseudomonas stutzeri ZoBell determined by NMR. Biophysical Journal 67(3): 1207-1215
Dalgarno, D.C.; Slater, L.; Chackalamannil, S.; Senior, M.M. 1992: Solution conformation of endothelin and point mutants by nuclear magnetic resonance spectroscopy. International Journal of Peptide and Protein Research 40(6): 515-523
Young, J.J.; Jung, L.J.; Liu, W.T.; Ho, S.N.; Chang, L.R.; Tsai, Y.C.; Bhaskaran, R.; Yu, C. 1994: Solution conformation of enopeptin A, a depsipeptide antibiotic, using 2D NMR and restrained molecular dynamics studies. Journal of Antibiotics 47(8): 922-931
Ishizu, T.; Fujiwara, M.; Yagi, A.; Noguchi, S. 1998: Solution conformation of ginseng tetrapeptide H-L-Val-gamma-D-Glu-D-Arg-Gly-OH. Chemical and Pharmaceutical Bulletin 46(4): 690-692
Donlan, M.L.; Brown, F.K.; Jeffs, P.W. 1992: Solution conformation of human big endothelin-1. Journal of Biomolecular NMR 2(5): 407-420
Stevens, E.S. 1992: Solution conformation of maltose from optical rotation: A procedure for evaluating carbohydrate force fields. Biopolymers 32(11): 1571-1579
Stevens, E.S.; Bystricky, S.; Hirsch, J. 1993: Solution conformation of methyl beta-xylobioside from optical rotation. Carbohydrate Research 239: 1-9
Bertho, G.; Ladam, P.; Gharbi-Benarous, J.; Delaforge, M.; Girault, J.P. 1998: Solution conformation of methylated macrolide antibiotics roxithromycin and erythromycin using NMR and molecular modelling. Ribosome-bound conformation determined by TRNOE and formation of cytochrome P450-metabolite complex. International Journal of Biological Macromolecules 22(2): 103-127
Venkateshwaran, T.G.; Stewart, J.T.; Bishop, R.T.; de Haseth, J.A.; Bartlett, M.G. 1998: Solution conformation of model peptides with the use of particle beam LC/FT-IR spectrometry and electrospray mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 17(1): 57-67
Segawa, M.; Ohno, Y.; Doi, M.; Ishida, T.; Iwashita, T. 1995: Solution conformation of mu-selective dermorphin and delta-selective deltorphin-I in phospholipid micelles, studied by NMR spectroscopy and molecular dynamics simulations. International Journal of Peptide and Protein Research 46(1): 37-46
Salvadori, S.; Picone, D.; Tancredi, T.; Guerrini, R.; Spadaccini, R.; Lazarus, L.H.; Regoli, D.; Temussi, P.A. 1997: Solution conformation of nociceptin. Biochemical and Biophysical Research Communications 233(3): 640-643
Ballio, A.; Bossa, F.; Di Giorgio, D.; Di Nola, A.; Manetti, C.; Paci, M.; Scaloni, A.; Segre, A.L. 1995: Solution conformation of the Pseudomonas syringae pv. syringae phytotoxic lipodepsipeptide syringopeptin 25-A. Two-dimensional NMR, distance geometry and molecular dynamics. European Journal of Biochemistry 234(3): 747-758
Harding, M.M.; Long, G.V.; Brown, C.L. 1993: Solution conformation of the antitumor drug streptonigrin. Journal of Medicinal Chemistry 36(21): 3056-3060
Tuma, R.; Russell, M.; Rosendahl, M.; Thomas, G.J. 1995: Solution conformation of the extracellular domain of the human tumor necrosis factor receptor probed by Raman and UV-resonance Raman spectroscopy: Structural effects of an engineered PEG linker. Biochemistry 34(46): 15150-15156
D'ursi, A.; Pegna, M.; Amodeo, P.; Molinari, H.; Verdini, A.; Zetta, L.; Temussi, P.A. 1992: Solution conformation of tuftsin. Biochemistry 31(40): 9581-9586
Siddiqui, M.Z.; Sharma, A.K.; Kumar, S. 1996: Solution conformation of tuftsin. International Journal of Biological Macromolecules 19(2): 99-102
Tatham, A.S.; Field, J.M.; Morris, V.J.; I'Anson, K.J.; Cardle, L.; Dufton, M.J.; Shewry, P.R. 1993: Solution conformational analysis of the alpha-zein proteins of maize. Journal of Biological Chemistry 268(35): 26253-26259
Cowley, D.J.; Pelton, J.T. 1995: Solution conformational dynamics of the C-terminal residues in endothelin-1 and some analogues: A time-resolved fluorescence study. International Journal of Peptide and Protein Research 46(1): 56-64
D'andrea, L.D.; Mazzeo, M.; Isernia, C.; Rossi, F.; Saviano, M.; Gallo, P.; Paolillo, L.; Pedone, C. 1997: Solution conformational preferences of a peptidic analogue of a natural macrolide. Biopolymers 42(3): 349-361
Laporte, L.; Stultz, J.; Thomas, G.J. 1997: Solution conformations and interactions of alpha and beta subunits of the Oxytricha nova telomere binding protein: investigation by Raman spectroscopy. Biochemistry 36(26): 8053-8059
Wu, P.; Lee, K.B.; Lee, Y.C.; Brand, L. 1996: Solution conformations of a biantennary glycopeptide and a series of its exoglycosidase products from sequential trimming of sugar residues. Journal of Biological Chemistry 271(3): 1470-1474
Kroenke, C.D.; Ziemnicka-Kotula, D.; Xu, J.; Kotula, L.; Palmer, A.G. 1997: Solution conformations of a peptide containing the cytoplasmic domain sequence of the beta amyloid precursor protein. Biochemistry 36(26): 8145-8152
Thennarasu, S.; Nagaraj, R. 1997: Solution conformations of peptides representing the sequence of the toxin pardaxin and analogues in trifluoroethanol-water mixtures: analysis of CD spectra. Biopolymers 41(6): 635-645
Cai, M.; Huang, Y.; Liu, J.; Krishnamoorthi, R. 1995: Solution conformations of proline rings in proteins studied by NMR spectroscopy. Journal of Biomolecular NMR 6(2): 123-128
Nikiforovich, G.V.; Prakash, O.M.; Gehrig, C.A.; Hruby, V.J. 1993: Solution conformations of the peptide backbone for DPDPE and its beta-MePhe4-substituted analogs. International Journal of Peptide and Protein Research 41(4): 347-361
Stroup, A.N.; Rockwell, A.L.; Gierasch, L.M. 1992: Solution conformations of two flexible cyclic pentapeptides: cyclo(Gly-Pro-D-Phe-Gly-Ala) and cyclo(Gly-Pro-D-Phe-Gly-Val). Biopolymers 32(12): 1713-1725
Purvis, D.H.; Mabbutt, B.C. 1997: Solution dynamics and secondary structure of murine leukemia inhibitory factor: a four-helix cytokine with a rigid CD loop. Biochemistry 36(33): 10146-10154
Hazlett, T.L.; Moore, K.J.; Lowe, P.N.; Jameson, D.M.; Eccleston, J.F. 1993: Solution dynamics of p21ras proteins bound with fluorescent nucleotides: a time-resolved fluorescence study. Biochemistry 32(49): 13575-13583
Horita, D.A.; Hajduk, P.J.; Lerner, L.E. 1997: Solution dynamics of the 1,2,3,4,6-penta-O-acetyl-alpha-D-idopyranose ring. Glycoconjugate Journal 14(5): 691-696
Gryk, M.R.; Finucane, M.D.; Zheng, Z.; Jardetzky, O. 1995: Solution dynamics of the trp repressor: a study of amide proton exchange by T1 relaxation. Journal of Molecular Biology 246(5): 618-627
Filgueiras, M.R.; La Torre, G.; Hench, L.L. 1993: Solution effects on the surface reactions of a bioactive glass. Journal of Biomedical Materials Research 27(4): 445-453
Filgueiras, M.R.; LaTorre, G.; Hench, L.L. 1993: Solution effects on the surface reactions of three bioactive glass compositions. Journal of Biomedical Materials Research 27(12): 1485-1493
Baraniuk, J.N. 1993: Solution hybridization with Hybond-mAP paper. Nucleic Acids Research 21(19): 4649-4650
Keener, C.R.; Fullerton, G.D.; Cameron, I.L.; Xiong, J. 1995: Solution nonideality related to solute molecular characteristics of amino acids. Biophysical Journal 68(1): 291-302
Qin, J.; La Mar, G.N.; Ascoli, F.; Brunori, M. 1993: Solution nuclear magnetic resonance determination of active site structure for a paramagnetic protein: cyanomet Aplysia myoglobin. Journal of Molecular Biology 231(4): 1009-1023
Gribb, M.M.; Sewell, G. 1998: Solution of ground water flow problems with general purpose and special purpose computer codes. Ground Water 36(2): 366-372
Jayaraman, V.K. 1993: Solution of hollow fibre bioreactor design equations for zero-order limit of Michaelis-Menten kinetics. Chemical Engineering Journal 51(3): B63-B66
Ducrocq, V.; Besbes, B. 1993: Solution of multiple trait animal models with missing data on some traits. Journal of Animal Breeding and Genetics 110(1-6): 81-92
Zhukov, V.O. 1994: Solution of pharmaceutical and chemical industry acute problems on the basis of creation of ecologically clean less-waste and non-waste technologies. Farmatsevtychnyi Zhurnal (Kiev) 1994(5-6): 87-89
Jungfermann, C.; Ahlers, F.; Grote, M.; Gubatz, S.; Steuernagel, S.; Thom, I.; Wetzels, G.; Wiermann, R. 1997: Solution of sporopollenin and reaggregation of a sporopollenin-like material: A new approach in the sporopollenin research. Journal of Plant Physiology 151(5): 513-519
Teso, A.; Drigo Filho, E.; Agostinho Neto, A. 1997: Solution of the Poisson-Boltzmann equation for a system with four ionic species. Journal of Mathematical Biology 35(7): 814-824
Dunn, W.J.; Hopfinger, A.J.; Catana, C.; Duraiswami, C. 1996: Solution of the conformation and alignment tensors for the binding of trimethoprim and its analogs to dihydrofolate reductase: 3D-quantitative structure-activity relationship study using molecular shape analysis, 3-way partial least-squares regression, and 3-way factor analysis. Journal of Medicinal Chemistry 39(24): 4825-4832
Cruse, H.; Steinkuehler, U. 1993: Solution of the direct and inverse kinematic problems by a common algorithm based on the mean of multiple computations. Biological Cybernetics 69(4): 345-351
Nierhaus, K.H. 1993: Solution of the ribosome riddle: How the ribosome selects the correct aminoacyl-tRNA out of 41 similar contestants. Molecular Microbiology 9(4): 661-669
Jurado-Molina, J.; Salas-De-Leon, D.-Alberto; Villasenor-Talavera, R. 1992: Solution of the von Bertalanffy's weight growth differential equation (1938) by two distinct methods. Anales del Instituto de Ciencias del Mar y Limnologia Universidad Nacional Autonoma de Mexico 19(2): 235-241
Cole, J.L.; Gehman, J.D.; Shafer, J.A.; Kuo, L.C. 1993: Solution oligomerization of the rev protein of HIV-1: Implications for function. Biochemistry 32(44): 11769-11775
An, H.; Wang, T.; Mohan, V.; Griffey, R., H.; Cook, P.D.n 1998: Solution phase combinatorial chemistry: Discovery of 13- and 15-membered polyazapyridinocyclophane libraries with antibacterial activity. Tetrahedron 54(16): 3999-4012
Neuville, L.; Zhu, J. 1997: Solution phase combinatorial synthesis of arylpiperazines. Tetrahedron Letters 38(23): 4091-4094
Panunzio, M.; Villa, M.; Missio, A.; Rossi, T.; Seneci, P. 1998: Solution phase library of perhydrooxazin-4-ones. Tetrahedron Letters 39(36): 6585-6588
Gervay, J.; Flaherty, T., M.; Nguyen, C. 1997: Solution phase synthesis of (1 fwdarw 5)-amide linked sugar amino acid dimers derived from sialic acids. Tetrahedron Letters 38(9): 1493-1496
Fokas, D.; Ryan, W., J.; Casebier, D., S.; Coffen, D., L. 1998: Solution phase synthesis of a spiro(pyrrolidine-2,3'-oxindole) library via a three component 1,3-dipolar cycloaddition reaction. Tetrahedron Letters 39(16): 2235-2238
Cheruvallath, Z.S.; Krotz, A.H.; Cole, D.L.; Ravikumar, V.T. 1997: Solution phase synthesis of an oligodeoxynucleotide phosphorothioate for therapeutic applications. Nucleosides and Nucleotides 16(7-9): 1625-1628
Kehler, J.; Puschl, A.; Dahl, O. 1997: Solution phase synthesis of dithymidine phosphorodithioate using new S-protecting groups in combination with a chemoselective coupling reagent (PyNOP). Nucleosides and Nucleotides 16(1-2): 23-32
Puschl, A.; Kehler, J.; Dahl, O. 1997: Solution phase synthesis of dithymidine phosphorothioate by a phosphotriester method using new S-protecting groups. Nucleosides and Nucleotides 16(1-2): 145-158
Nolan, S.J.; Vyas, R.R.; Hingerty, B.E.; Ellis, S.; Broyde, S.; Shapiro, R.; Basu, A.K. 1996: Solution properties and computational analysis of an oligodeoxynucleotide containing N-(deoxyguanosin-8-yl)-1-aminopyrene. Carcinogenesis 17(1): 133-144
Kortt, A.A.; Guthrie, R.E.; Hinds, M.G.; Power, B.E.; Ivancic, N.; Caldwell, J.B.; Gruen, L.C.; Norton, R.S.; Hudson, P.J. 1995: Solution properties of Escherichia coli-expressed VH domain of anti-neuraminidase antibody NC41. Journal of Protein Chemistry 14(3): 167-178
Grimm, A.; Krueger, E.; Burchard, W. 1995: Solution properties of beta-D-(1,3)(1,4)-glucan isolated from beer. Carbohydrate Polymers 27(3): 205-214
Anthonsen, M., W.; Varum, K., M.; Smidsrod, O. 1993: Solution properties of chitosans: Conformation and chain stiffness of chitosans with different degrees of N-acetylation. Carbohydrate Polymers 22(3): 193-201
Kasapis, S.; Morris, E., R.; Gross, M.; Rudolph, K. 1994: Solution properties of levan polysaccharide from Pseudomonas syringae pv. phaseolicola, and its possible primary role as a blocker of recognition during pathogenesis. Carbohydrate Polymers 23(1): 55-64
Campos, A.; Garcia, R.; Porcar, I.; Soria, V. 1994: Solution properties of poly-electrolytes: XI. Adsorption effects in aqueous size-exclusion chromatography of polyanions. Journal of Liquid Chromatography 17(14-15): 3261-3283
Garcia, R.; Porcar, I.; Figueruelo, J., E.; Soria, V.; Campos, A. 1996: Solution properties of polyelectrolytes XII. Semi-quantitative approach to mixed electrostatic and hydrophobic polymer-gel interactions. Journal of Chromatography A 721(2): 203-212
Flaibani, A.; Leonhartsberger, S.; Navarini, L.; Cescutti, P.; Paoletti, S. 1994: Solution properties of the capsular polysaccharide produced by Klebsiella pneumoniae K40. International Journal of Biological Macromolecules 16(2): 65-70
Cescutti, P.; Paoletti, S.; Navarini, L.; Flaibani, A. 1993: Solution properties of the capsular polysaccharide produced by Klebsiella pneumoniae SK1. International Journal of Biological Macromolecules 15(4): 201-207
Abatangelo, A.; Gilli, R.; Navarini, L.; Rizzo, R.; Osman, S.F.; Fett, W.F. 1997: Solution properties of the exopolysaccharide produced by Pseudomonas marginalis strain HT041B. Journal of Carbohydrate Chemistry 16(4-5): 583-598
Prankerd, R.J. 1995: Solution properties of two fluoroquinolone antibacterials. Pharmaceutical Research 12(4): 634-635
Kappatos, T.; Gordon, M.H.; Birch, G.G. 1996: Solution properties of vanillin and diacetyl in aqueous-ethanol solutions. Food Chemistry 57(2): 275-282
Ebringerova, A.; Hromadkova, Z.; Burchard, W.; Dolega, R.; Vorwerg, W. 1994: Solution properties of water-insoluble rye-bran arabinoxylan. Carbohydrate Polymers 24(3): 161-169
Goycoolea, F.M.; Morris, E.R.; Richardson, R.K.; Bell, A.E. 1995: Solution rheology of mesquite gum in comparison with gum arabic. Carbohydrate Polymers 27(1): 37-45
Svergun, D.I.; Pedersen, J.S.; Serdyuk, I.N.; Koch, M.H. 1994: Solution scattering from 50S ribosomal subunit resolves inconsistency between electron microscopic models. Proceedings of the National Academy of Sciences of the United States of America 91(25): 11826-11830
Svergun, D.I.; Burkhardt, N.; Pedersen, J.S.; Koch, M.H.; Volkov, V.V.; Kozin, M.B.; Meerwink, W.; Stuhrmann, H.B.; Diedrich, G.; Nierhaus, K.H. 1997: Solution scattering structural analysis of the 70 S Escherichia coli ribosome by contrast variation. I. Invariants and validation of electron microscopy models. Journal of Molecular Biology 271(4): 588-601
Svergun, D.I.; Burkhardt, N.; Pedersen, J.S.; Koch, M.H.; Volkov, V.V.; Kozin, M.B.; Meerwink, W.; Stuhrmann, H.B.; Diedrich, G.; Nierhaus, K.H. 1997: Solution scattering structural analysis of the 70 S Escherichia coli ribosome by contrast variation. II. a model of the ribosome and its RNA at 3.5 nm resolution. Journal of Molecular Biology 271(4): 602-618
Campbell, A.P.; Bautista, D.L.; Tripet, B.; Wong, W.Y.; Irvin, R.T.; Hodges, R.S.; Sykes, B.D. 1997: Solution secondary structure of a bacterially expressed peptide from the receptor binding domain of Pseudomonas aeruginosa pili strain PAK: a heteronuclear multidimensional NMR study. Biochemistry 36(42): 12791-12801
Slupsky, C.M.; Reinach, F.C.; Smillie, L.B.; Sykes, B.D. 1995: Solution secondary structure of calcium-saturated troponin C monomer determined by multidimensional heteronuclear NMR spectroscopy. Protein Science: a Publication of the Protein Society 4(7): 1279-1290
Wilbanks, S.M.; Chen, L.; Tsuruta, H.; Hodgson, K.O.; Mckay, D.B. 1995: Solution small-angle X-ray scattering study of the molecular chaperone Hsc70 and its subfragments. Biochemistry 34(38): 12095-12106
Rao, C.P.; Geetha, K.; Bandwar, R.P. 1992: Solution stability of iron-saccharide complexes. Bioorganic and Medicinal Chemistry Letters 2(9): 997-1002
Morita, H.; Gonda, A.; Takeya, K.; Itokawa, H.; Hirano, T.; Oka, K.; Shirota, O. 1997: Solution state conformation of an immunosuppressive cyclic dodecapeptide, cycloleonurinin. Tetrahedron 53(22): 7469-7478
Neugebauer, W.; Barbier, J.R.; Sung, W.L.; Whitfield, J.F.; Willick, G.E. 1995: Solution structure and adenylyl cyclase stimulating activities of C-terminal truncated human parathyroid hormone analogues. Biochemistry 34(27): 8835-8842
Volkman, B.F.; Alam, S.L.; Satterlee, J.D.; Markley, J.L. 1998: Solution structure and backbone dynamics of component IV Glycera dibranchiata monomeric hemoglobin-CO. Biochemistry 37(31): 10906-10919
Liu, J.; Prakash, O.; Cai, M.; Gong, Y.; Huang, Y.; Wen, L.; Wen, J.J.; Huang, J.K.; Krishnamoorthi, R. 1996: Solution structure and backbone dynamics of recombinant Cucurbita maxima trypsin inhibitor-V determined by NMR spectroscopy. Biochemistry 35(5): 1516-1524
Sorensen, M.D.; Bjorn, S.; Norris, K.; Olsen, O.; Petersen, L.; James, T.L.; Led, J.J. 1997: Solution structure and backbone dynamics of the human alpha3-chain type VI collagen C-terminal Kunitz domain,. Biochemistry 36(34): 10439-10450
Düx, P.; Rubinstenn, G.; Vuister, G.W.; Boelens, R.; Mulder, F.A.; Hård, K.; Hoff, W.D.; Kroon, A.R.; Crielaard, W.; Hellingwerf, K.J.; Kaptein, R. 1998: Solution structure and backbone dynamics of the photoactive yellow protein. Biochemistry 37(37): 12689-12699
Nonin, S.; Phan, A.T.; Leroy, J.L. 1997: Solution structure and base pair opening kinetics of the i-motif dimer of d(5mCCTTTACC): A noncanonical structure with possible roles in chromosome stability. Structure 5(9): 1231-1246
Langowski, J.; Kapp, U.; Klenin, K.; Vologodskii, A. 1994: Solution structure and dynamics of DNA topoisomers: Dynamic light scattering studies and Monte Carlo simulations. Biopolymers 34(5): 639-646
Liepinsh, E.; Berndt, K.D.; Sillard, R.; Mutt, V.; Otting, G. 1994: Solution structure and dynamics of PEC-60, a protein of the Kazal type inhibitor family, determined by nuclear magnetic resonance spectroscopy. Journal of Molecular Biology 239(1): 137-153
Mossing, M.C. 1998: Solution structure and dynamics of a designed monomeric variant of the lambda Cro repressor. Protein Science: a Publication of the Protein Society 7(4): 983-993
McGroddy, K.A.; Oswald, R.E. 1993: Solution structure and dynamics of cyclic and acyclic cholinergic agonists. Biophysical Journal 64(2): 314-324
Copié, V.; Tomita, Y.; Akiyama, S.K.; Aota, S.; Yamada, K.M.; Venable, R.M.; Pastor, R.W.; Krueger, S.; Torchia, D.A. 1998: Solution structure and dynamics of linked cell attachment modules of mouse fibronectin containing the RGD and synergy regions: Comparison with the human fibronectin crystal structure. Journal of Molecular Biology 277(3): 663-682
Kraulis, P.J.; Domaille, P.J.; Campbell Burk, S.L.; Van Aken, T.; Laue, E.D. 1994: Solution structure and dynamics of ras p21 cntdot GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy. Biochemistry 33(12): 3515-3531
McDonnell, J.M.; Fushman, D.; Cahill, S.M.; Zhou, W.; Wolven, A.; Wilson, C.B.; Nelle, T.D.; Resh, M.D.; Wills, J.; Cowburn, D. 1998: Solution structure and dynamics of the bioactive retroviral M domain from Rous sarcoma virus. Journal of Molecular Biology 279(4): 921-928
Chuang, W.J.; Abeygunawardana, C.; Gittis, A.G.; Pedersen, P.L.; Mildvan, A.S. 1995: Solution structure and function in trifluoroethanol of PP-50, an ATP-binding peptide from F1ATPase. Archives of biochemistry and biophysics 319(1): 110-122
Beglova, N.; LeSauteur, L.; Ekiel, I.; Saragovi, H.U.; Gehring, K. 1998: Solution structure and internal motion of a bioactive peptide derived from nerve growth factor. Journal of Biological Chemistry 273(37): 23652-23658
Kohda, D.; Terasawa, H.; Ichikawa, S.; Ogura, K.; Hatanaka, H.; Mandiyan, V.; Ullrich, A.; Schlessinger, J.; Inagaki, F. 1994: Solution structure and ligand-binding site of the carboxy-terminal SH3 domain of GRB2. Structure 2(11): 1029-1040
Gomar, J.; Petit, M.C.; Sodano, P.; Sy, D.; Marion, D.; Kader, J.C.; Vovelle, F.; Ptak, M. 1996: Solution structure and lipid binding of a nonspecific lipid transfer protein extracted from maize seeds. Protein Science: a Publication of the Protein Society 5(4): 565-577
Pääkkönen, K.; Annila, A.; Sorsa, T.; Pollesello, P.; Tilgmann, C.; Kilpeläinen, I.; Karisola, P.; Ulmanen, I.; Drakenberg, T. 1998: Solution structure and main chain dynamics of the regulatory domain (Residues 1-91) of human cardiac troponin C. Journal of Biological Chemistry 273(25): 15633-15638
Morton, C.J.; Pugh, D.J.; Brown, E.L.; Kahmann, J.D.; Renzoni, D.A.; Campbell, I.D. 1996: Solution structure and peptide binding of the SH3 domain from human Fyn. Structure 4(6): 705-714
Arvidsson, K.; Jarvet, J.; Allard, P.; Ehrenberg, A. 1994: Solution structure by 1H and dynamics by natural abundance 13C NMR of a receptor recognising peptide derived from a C-terminal fragment of neuropeptide Y. Journal of Biomolecular NMR 4(5): 653-672
Gasymov, O.K.; Abduragimov, A.R.; Yusifov, T.N.; Glasgow, B.J. 1997: Solution structure by site directed tryptophan fluorescence in tear lipocalin. Biochemical and Biophysical Research Communications 239(1): 191-196
Bondon, A.; Berthault, P.; Segalas, I.; Perly, B.; Wróblewski, H. 1995: Solution structure determination by NMR spectroscopy of a synthetic peptide corresponding to a putative amphipathic alpha-helix of spiralin: resonance assignment, distance geometry and simulated annealing. Biochimica et Biophysica Acta 1235(2): 169-177
Rajarathnam, K.; Qin, J.; La-Mar, G., N.; Chiu, M., L.; Sligar, S., G. 1993: Solution structure determination of the heme cavity in the E7 His fwdarw Val cyano-met myoglobin point mutant based on the proton NMR detected dipolar field of the iron: Evidence for contraction of the heme pocket. Biochemistry 32(21): 5670-5680
Wu, Z.R.; Ebrahimian, S.; Zawrotny, M.E.; Thornburg, L.D.; Perez-Alvarado, G.C.; Brothers, P.; Pollack, R.M.; Summers, M.F. 1997: Solution structure of 3-oxo-delta5-steroid isomerase. Science 276(5311): 415-418
Tassin, S.; Broekaert, W.F.; Marion, D.; Acland, D.P.; Ptak, M.; Vovelle, F.; Sodano, P. 1998: Solution structure of Ace-AMP1, a potent antimicrobial protein extracted from onion seeds. Structural analogies with plant nonspecific lipid transfer proteins. Biochemistry 37(11): 3623-3637
Hanzawa, H.; Haruyama, H.; Konishi, K.; Watanabe, K.; Tsurufuji, S. 1998: Solution structure of CINC/Gro investigated by heteronuclear NMR. Journal of Biochemistry 123(1): 62-70
Morikis, D.; Assa-Munt, N.; Sahu, A.; Lambris, J.D. 1998: Solution structure of Compstatin, a potent complement inhibitor. Protein Science: a Publication of the Protein Society 7(3): 619-627
Messias, A.C.; Kastrau, D.H.; Costa, H.S.; LeGall, J.; Turner, D.L.; Santos, H.; Xavier, A.V. 1998: Solution structure of Desulfovibrio vulgaris (Hildenborough) ferrocytochrome c3: structural basis for functional cooperativity. Journal of Molecular Biology 281(4): 719-739
Lepre, C.A.; Pearlman, D.A.; Cheng, J.W.; DeCenzo, M.T.; Livingston, D.J.; Moore, J.M. 1994: Solution structure of FK506 bound to the R42K, H87V double mutant of FKBP-12. Biochemistry 33(46): 13571-13580
Yang, Y.S.; Garbay, C.; Duchesne, M.; Cornille, F.; Jullian, N.; Fromage, N.; Tocque, B.; Roques, B.P. 1994: Solution structure of GAP SH3 domain by 1H NMR and spatial arrangement of essential Ras signaling-involved sequence. EMBO Journal 13(6): 1270-1279
Nibedita, R.; Kumar, R.A.; Majumdar, A.; Hosur, R.V.; Govil, G.; Majumder, K.; Chauhan, V.S. 1993: Solution structure of GCCAAT recognition motif by 2D NMR, spectral simulation, molecular modeling, and distance geometry calculations. Biochemistry 32(35): 9053-9064
Kato, R.; Takahashi, O.; Kiso, Y.; Moriguchi, I.; Hirono, S. 1994: Solution structure of HIV-1 protease-allophenylnorstatine derivative inhibitor complex obtained from molecular dynamics simulation. Chemical and Pharmaceutical Bulletin 42(1): 176-178
Meunier, S.; Bernassau, J.M.; Sabatier, J.M.; Martin-Eauclaire, M.F.; Van Rietschoten, J.; Cambillau, C.; Darbon, H. 1993: Solution structure of P05-NH2, a scorpion toxin analog with high affinity for the apamin-sensitive potassium channel. Biochemistry 32(45): 11969-11976
Mer, G.; Hietter, H.; Kellenberger, C.; Renatus, M.; Luu, B.; Lefèvre, J.F. 1996: Solution structure of PMP-C: a new fold in the group of small serine proteinase inhibitors. Journal of Molecular Biology 258(1): 158-171
Francart, C.; Dauchez, M.; Alix, A.J.; Lippens, G. 1997: Solution structure of R-elafin, a specific inhibitor of elastase. Journal of Molecular Biology 268(3): 666-677
Spielmann, H.P.; Wemmer, D.E.; Jacobsen, J.P. 1995: Solution structure of a DNA complex with the fluorescent bis-intercalator TOTO determined by NMR spectroscopy. Biochemistry 34(27): 8542-8553
Foti, M.; Marshalko, S.; Schurter, E.; Kumar, S.; Beardsley, G.P.; Schweitzer, B.I. 1997: Solution structure of a DNA decamer containing the antiviral drug ganciclovir: combined use of NMR, restrained molecular dynamics, and full relaxation matrix refinement. Biochemistry 36(18): 5336-5345
Schweitzer, B.I.; Mikita, T.; Kellogg, G.W.; Gardner, K.H.; Beardsley, G.P. 1994: Solution structure of a DNA dodecamer containing the anti-neoplastic agent arabinosylcytosine: Combined use of NMR, restrained molecular dynamics, and full relaxation matrix refinement. Biochemistry 33(38): 11460-11475
Cullinan, D.; Johnson, F.; Grollman, A.P.; Eisenberg, M.; de los Santos, C. 1997: Solution structure of a DNA duplex containing the exocyclic lesion 3,N4-etheno-2'-deoxycytidine opposite 2'-deoxyguanosine. Biochemistry 36(39): 11933-11943
Cain, R.J.; Zuiderweg, E.R.; Glick, G.D. 1995: Solution structure of a DNA hairpin and its disulfide cross-linked analog. Nucleic Acids Research 23(12): 2153-2160
Schmitz, U.; Sethson, I.; Egan, W.M.; James, T.L. 1992: Solution structure of a DNA octamer containing the Pribnow box via restrained molecular dynamics simulation with distance and torsion angle constraints derived from two-dimensional nuclear magnetic resonance spectral fitting. Journal of Molecular Biology 227(2): 510-531
Kettani, A.; Kumar, R.A.; Patel, D.J. 1995: Solution structure of a DNA quadruplex containing the fragile X syndrome triplet repeat. Journal of Molecular Biology 254(4): 638-656
Read, C.M.; Cary, P.D.; Crane-Robinson, C.; Driscoll, P.C.; Norman, D.G. 1993: Solution structure of a DNA-binding domain from HMG1. Nucleic Acids Research 21(15): 3427-3436
Butcher, S.E.; Dieckmann, T.; Feigon, J. 1997: Solution structure of a GAAA tetraloop receptor RNA. EMBO Journal 16(24): 7490-7499
Berthault, P.; Birlirakis, N.; Rubinstenn, G.; Sinaÿ, P.; Desvaux, H. 1996: Solution structure of a Lewis(x) analogue by off-resonance 1H NMR spectroscopy without use of an internal distance reference. Journal of Biomolecular NMR 8(1): 23-35
Sivaraja, M.; Botfield, M.C.; Mueller, M.; Jancso, A.; Weiss, M.A. 1994: Solution structure of a POU-specific homeodomain: 3D-NMR studies of human B-cell transcription factor Oct-2. Biochemistry 33(33): 9845-9855
Liu, D.; Ishima, R.; Tong, K.I.; Bagby, S.; Kokubo, T.; Muhandiram, D.R.; Kay, L.E.; Nakatani, Y.; Ikura, M. 1998: Solution structure of a TBP-TAF(II)230 complex: protein mimicry of the minor groove surface of the TATA box unwound by TBP. Cell 94(5): 573-583
Doyle, P.M.; Harris, J.C.; Moody, C.M.; Sadler, P.J.; Sims, M.; Thornton, J.M.; Uppenbrink, J.; Viles, J.H. 1996: Solution structure of a biologically active cyclic LDV peptide analogue containing a type II' beta-turn mimetic. International Journal of Peptide and Protein Research 47(6): 427-436
Morgan, W.D.; Birdsall, B.; Polshakov, V.I.; Sali, D.; Kompis, I.; Feeney, J. 1995: Solution structure of a brodimoprim analogue in its complex with Lactobacillus casei dihydrofolate reductase. Biochemistry 34(37): 11690-11702
Xu, G.Y.; Ong, E.; Gilkes, N.R.; Kilburn, D.G.; Muhandiram, D.R.; Harris-Brandts, M.; Carver, J.P.; Kay, L.E.; Harvey, T.S. 1995: Solution structure of a cellulose-binding domain from Cellulomonas fimi by nuclear magnetic resonance spectroscopy. Biochemistry 34(21): 6993-7009
Huang, H.; Zhu, L.; Reid, B.R.; Drobny, G.P.; Hopkins, P.B. 1995: Solution structure of a cisplatin-induced DNA interstrand cross-link. Science 270(5243): 1842-1845
Mujeeb, A.; Kerwin, S.M.; Kenyon, G.L.; James, T.L. 1993: Solution structure of a conserved DNA sequence from the HIV-1 genome: Restrained molecular dynamics simulation with distance and torsion angle restraints derived from two-dimensional NMR spectra. Biochemistry 32(49): 13419-13431
Pagel, M.D.; Wemmer, D.E. 1994: Solution structure of a core peptide derived from scyllatoxin. Proteins 18(3): 205-215
Jois, S.D.; Tambunan, U.S.; Chakrabarti, S.; Siahaan, T.J. 1996: Solution structure of a cyclic RGD peptide that inhibits platelet aggregation. Journal of Biomolecular Structure and Dynamics 14(1): 1-11
Kuroda, Y.; Nakai, T.; Ohkubo, T. 1994: Solution structure of a de novo helical protein by 2D-NMR spectroscopy. Journal of Molecular Biology 236(3): 862-868
Wang, K.Y.; Parker, S.A.; Goljer, I.; Bolton, P.H. 1997: Solution structure of a duplex DNA with an abasic site in a dA tract. Biochemistry 36(39): 11629-11639
Ségalas, I.; Roumestand, C.; Zinn-Justin, S.; Gilquin, B.; Ménez, R.; Ménez, A.; Toma, F. 1995: Solution structure of a green mamba toxin that activates muscarinic acetylcholine receptors, as studied by nuclear magnetic resonance and molecular modeling. Biochemistry 34(4): 1248-1260
Kumar, S.; Reed, M.W.; Gamper, H.B.; Gorn, V.V.; Lukhtanov, E.A.; Foti, M.; West, J.; Meyer, R.B.; Schweitzer, B.I. 1998: Solution structure of a highly stable DNA duplex conjugated to a minor groove binder. Nucleic Acids Research 26(3): 831-838
Sodano, P.; Hartmann, B.; Rose, T.; Wain-Hobson, S.; Delepierre, M. 1995: Solution structure of a homopyrimidine: homopurine dodecamer encoded by the HIV-1 envelope gene: NMR and molecular simulation studies. Biochemistry 34(20): 6900-6910
Katahira, R.; Doi, M.; Kyogoku, Y.; Yamada-Nosaka, A.; Yamasaki, K.; Takai, M.; Kobayashi, Y. 1995: Solution structure of a human calcitonin analog elucidated by NMR and distance geometry calculations. International Journal of Peptide and Protein Research 45(4): 305-311
Tate, S.; Ushioda, T.; Utsunomiya-Tate, N.; Shibuya, K.; Ohyama, Y.; Nakano, Y.; Kaji, H.; Inagaki, F.; Samejima, T.; Kainosho, M. 1995: Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A. Biochemistry 34(45): 14637-14648
Logan, T.M.; Zhou, M.M.; Nettesheim, D.G.; Meadows, R.P.; Van Etten, R.L.; Fesik, S.W. 1994: Solution structure of a low molecular weight protein tyrosine phosphatase. Biochemistry 33(37): 11087-11096
Kieft, J.S.; Tinoco, I. 1997: Solution structure of a metal-binding site in the major groove of RNA complexed with cobalt (III) hexammine. Structure 5(5): 713-721
De Wolf, E.; Gill, R.; Geddes, S.; Pitts, J.; Wollmer, A.; Grötzinger, J. 1996: Solution structure of a mini IGF-1. Protein Science: a Publication of the Protein Society 5(11): 2193-2202
Hammarström, A.; Berndt, K.D.; Sillard, R.; Adermann, K.; Otting, G. 1996: Solution structure of a naturally-occurring zinc-peptide complex demonstrates that the N-terminal zinc-binding module of the Lasp-1 LIM domain is an independent folding unit. Biochemistry 35(39): 12723-12732
Downing, A.K.; Knott, V.; Werner, J.M.; Cardy, C.M.; Campbell, I.D.; Handford, P.A. 1996: Solution structure of a pair of calcium-binding epidermal growth factor-like domains: Implications for the Marfan Syndrome and other genetic disorders. Cell 85(4): 597-605
Barlow, P.N.; Steinkasserer, A.; Norman, D.G.; Kieffer, B.; Wiles, A.P.; Sim, R.B.; Campbell, I.D. 1993: Solution structure of a pair of complement modules by nuclear magnetic resonance. Journal of Molecular Biology 232(1): 268-284
Williams, M.J.; Phan, I.; Harvey, T.S.; Rostagno, A.; Gold, L.I.; Campbell, I.D. 1994: Solution structure of a pair of fibronectin type 1 modules with fibrin binding activity. Journal of Molecular Biology 235(4): 1302-1311
Chen, Y.; Tucker, A.; Wallace, B.A. 1996: Solution structure of a parallel left-handed double-helical gramicidin-A determined by 2D 1H NMR. Journal of Molecular Biology 264(4): 757-769
Wang, Y.; Patel, D.J. 1993: Solution structure of a parallel-stranded G-quadruplex DNA. Journal of Molecular Biology 234(4): 1171-1183
Aboul-ela, F.; Murchie, A.I.; Norman, D.G.; Lilley, D.M. 1994: Solution structure of a parallel-stranded tetraplex formed by d(TG4T) in the presence of sodium ions by nuclear magnetic resonance spectroscopy. Journal of Molecular Biology 243(3): 458-471
Smith, L.J.; Alexandrescu, A.T.; Pitkeathly, M.; Dobson, C.M. 1994: Solution structure of a peptide fragment of human alpha-lactalbumin in trifluoroethanol: a model for local structure in the molten globule. Structure 2(8): 703-712
Ni, F.; Ripoll, D.R.; Martin, P.D.; Edwards, B.F. 1992: Solution structure of a platelet receptor peptide bound to bovine alpha-thrombin. Biochemistry 31(46): 11551-11557
Wang, E.; Koshlap, K.M.; Gillespie, P.; Dervan, P.B.; Feigon, J. 1996: Solution structure of a pyrimidine-purine-pyrimidine triplex containing the sequence-specific intercalating non-natural base D3. Journal of Molecular Biology 257(5): 1052-1069
Bornet, O.; Lancelot, G. 1995: Solution structure of a selectively 13C-labeled intramolecular DNA triplex. Journal of Biomolecular Structure and Dynamics 12(4): 803-814
Ogata, K.; Morikawa, S.; Nakamura, H.; Sekikawa, A.; Inoue, T.; Kanai, H.; Sarai, A.; Ishii, S.; Nishimura, Y. 1994: Solution structure of a specific DNA complex of the Myb DNA-binding domain with cooperative recognition helices. Cell 79(4): 639-648
Diener, J.L.; Moore, P.B. 1998: Solution structure of a substrate for the archaeal pre-tRNA splicing endonucleases: The bulge-helix-bulge motif. Molecular Cell 1(6): 883-894
Natarajan, K.; Cowan, J.A. 1998: Solution structure of a synthetic lytic peptide: The perforin amino terminus. Chemistry and Biology 5(3): 147-154
Carr, M.D.; Bauer, C.J.; Gradwell, M.J.; Feeney, J. 1994: Solution structure of a trefoil-motif-containing cell growth factor, porcine spasmolytic protein. Proceedings of the National Academy of Sciences of the United States of America 91(6): 2206-2210
Bundle, D.R.; Baumann, H.; Brisson, J.R.; Gagné, S.M.; Zdanov, A.; Cygler, M. 1994: Solution structure of a trisaccharide-antibody complex: comparison of NMR measurements with a crystal structure. Biochemistry 33(17): 5183-5192
Stassinopoulos, A.; Ji, J.; Gao, X.; Goldberg, I.H. 1996: Solution structure of a two-base DNA bulge complexed with an enediyne cleaving analog. Science 272(5270): 1943-1946
Pickford, A.R.; Potts, J.R.; Bright, J.R.; Phan, I.; Campbell, I.D. 1997: Solution structure of a type 2 module from fibronectin: Implications for the structure and function of the gelatin-binding domain. Structure 5(3): 359-370
Zhang, X.; Boyar, W.; Galakatos, N.; Gonnella, N.C. 1997: Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding. Protein Science: a Publication of the Protein Society 6(1): 65-72
Klaus, W.; Schomburg, D. 1993: Solution structure of a variant of human pancreatic secretory trypsin inhibitor determined by nuclear magnetic resonance spectroscopy. Journal of Molecular Biology 229(3): 695-706
Lozano, R.M.; Jiménez, M.; Santoro, J.; Rico, M.; Giménez-Gallego, G. 1998: Solution structure of acidic fibroblast growth factor bound to 1,3, 6-naphthalenetrisulfonate: a minimal model for the anti-tumoral action of suramins and suradistas. Journal of Molecular Biology 281(5): 899-915
Coles, M.; Bicknell, W.; Watson, A.A.; Fairlie, D.P.; Craik, D.J. 1998: Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?. Biochemistry 37(31): 11064-11077
Dieckmann, T.; Suzuki, E.; Nakamura, G.K.; Feigon, J. 1996: Solution structure of an ATP-binding RNA aptamer reveals a novel fold. Rna 2(7): 628-640
Yi, G.S.; Park, C.B.; Kim, S.C.; Cheong, C. 1996: Solution structure of an antimicrobial peptide buforin II. FEBS Letters 398(1): 87-90
Ji, J.; Hogan, M.E.; Gao, X. 1996: Solution structure of an antiparallel purine motif triplex containing a T.CG pyrimidine base triple. Structure 4(4): 425-435
Olsen, H.B.; Ludvigsen, S.; Kaarsholm, N.C. 1996: Solution structure of an engineered insulin monomer at neutral pH. Biochemistry 35(27): 8836-8845
Yamasaki, K.; Naito, S.; Anaguchi, H.; Ohkubo, T.; Ota, Y. 1997: Solution structure of an extracellular domain containing WSXWS motif of the granulocyte colony-stimulating factor receptor and its interaction with ligand. Nature Structural Biology 4(6): 498-508
Phipps, A.K.; Tarköy, M.; Schultze, P.; Feigon, J. 1998: Solution structure of an intramolecular DNA triplex containing 5-(1-propynyl)-2'-deoxyuridine residues in the third strand. Biochemistry 37(17): 5820-5830
Koshlap, K.M.; Schultze, P.; Brunar, H.; Dervan, P.B.; Feigon, J. 1997: Solution structure of an intramolecular DNA triplex containing an N7-glycosylated guanine which mimics a protonated cytosine. Biochemistry 36(9): 2659-2668
Tarköy, M.; Phipps, A.K.; Schultze, P.; Feigon, J. 1998: Solution structure of an intramolecular DNA triplex linked by hexakis(ethylene glycol) units: d(AGAGAGAA-(EG)6-TTCTCTCT-(EG)6-TCTCTCTT). Biochemistry 37(17): 5810-5819
Constantine, K.L.; Friedrichs, M.S.; Metzler, W.J.; Wittekind, M.; Hensley, P.; Mueller, L. 1994: Solution structure of an isolated antibody VL domain. Journal of Molecular Biology 236(1): 310-327
Zegar, I.S.; Stone, M.P. 1996: Solution structure of an oligodeoxynucleotide containing the human N-ras codon 12 sequence refined from 1H NMR using molecular dynamics restrained by nuclear overhauser effects. Chemical Research in Toxicology 9(1): 114-125
Feng, B.; Stone, M.P. 1995: Solution structure of an oligodeoxynucleotide containing the human n-ras codon 61 sequence refined from 1H NMR using molecular dynamics restrained by nuclear Overhauser effects. Chemical Research in Toxicology 8(6): 821-832
Korobka, A.; Cullinan, D.; Cosman, M.; Grollman, A.P.; Patel, D.J.; Eisenberg, M.; de los Santos, C. 1996: Solution structure of an oligodeoxynucleotide duplex containing the exocyclic lesion 3,N4-etheno-2'-deoxycytidine opposite 2'-deoxyadenosine, determined by NMR spectroscopy and restrained molecular dynamics. Biochemistry 35(41): 13310-13318
Lequin, O.; Albaret, C.; Bontems, F.; Spik, G.; Lallemand, J.Y. 1996: Solution structure of bovine angiogenin by 1H nuclear magnetic resonance spectroscopy. Biochemistry 35(27): 8870-8880
Zimmermann, G.R.; Legault, P.; Selsted, M.E.; Pardi, A. 1995: Solution structure of bovine neutrophil beta-defensin-12: The peptide fold of the beta-defensins is identical to that of the classical defensins. Biochemistry 34(41): 13663-13671
Drohat, A.C.; Baldisseri, D.M.; Rustandi, R.R.; Weber, D.J. 1998: Solution structure of calcium-bound rat S100B(betabeta) as determined by nuclear magnetic resonance spectroscopy,. Biochemistry 37(9): 2729-2740
Osawa, M.; Swindells, M.B.; Tanikawa, J.; Tanaka, T.; Mase, T.; Furuya, T.; Ikura, M. 1998: Solution structure of calmodulin-W-7 complex: the basis of diversity in molecular recognition. Journal of Molecular Biology 276(1): 165-176
Singhal, A.K.; Chien, K.Y.; Wu, W.G.; Rule, G.S. 1993: Solution structure of cardiotoxin V from Naja naja atra. Biochemistry 32(31): 8036-8044
Brantl, V.; Picone, D.; Amodeo, P.; Temussi, P.A. 1993: Solution structure of casokefamide. Biochemical and Biophysical Research Communications 191(3): 853-859
Hsu, V.L.; Armitage, I.M. 1992: Solution structure of cyclosporin A and a nonimmunosuppressive analog bound to fully deuterated cyclophilin. Biochemistry 31(51): 12778-12784
Beissinger, M.; Sticht, H.; Sutter, M.; Ejchart, A.; Haehnel, W.; Rösch, P. 1998: Solution structure of cytochrome c6 from the thermophilic cyanobacterium Synechococcus elongatus. EMBO Journal 17(1): 27-36
Pieroni, O.; Fissi, A.; Jain, R.M.; Chauhan, V.S. 1996: Solution structure of dehydropeptides: a CD investigation. Biopolymers 38(1): 97-108
Burgering, M.J.; Boelens, R.; Gilbert, D.E.; Breg, J.N.; Knight, K.L.; Sauer, R.T.; Kaptein, R. 1994: Solution structure of dimeric Mnt repressor (1-76). Biochemistry 33(50): 15036-15045
Landon, C.; Sodano, P.; Hetru, C.; Hoffmann, J.; Ptak, M. 1997: Solution structure of drosomycin, the first inducible antifungal protein from insects. Protein Science: a Publication of the Protein Society 6(9): 1878-1884
Lin, Z.; Hung, K.N.; Grollman, A.P.; de los Santos, C. 1998: Solution structure of duplex DNA containing an extrahelical abasic site analog determined by NMR spectroscopy and molecular dynamics. Nucleic Acids Research 26(10): 2385-2391
Crump, M.P.; Rajarathnam, K.; Kim, K.S.; Clark-Lewis, I.; Sykes, B.D. 1998: Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation. Journal of Biological Chemistry 273(35): 22471-22479
Hatanaka, H.; Tanimura, R.; Katoh, S.; Inagaki, F. 1997: Solution structure of ferredoxin from the thermophilic cyanobacterium Synechococcus elongatus and its thermostability. Journal of Molecular Biology 268(5): 922-933
Nicotra, M.; Paci, M.; Sette, M.; Oakley, A.J.; Parker, M.W.; Lo Bello, M.; Caccuri, A.M.; Federici, G.; Ricci, G. 1998: Solution structure of glutathione bound to human glutathione transferase P1-1: comparison of NMR measurements with the crystal structure. Biochemistry 37(9): 3020-3027
Ebel, C.; Altekar, W.; Langowski, J.; Urbanke, C.; Forest, E.; Zaccai, G. 1995: Solution structure of glyceraldehyde-3-phosphate dehydrogenase from Haloarcula vallismortis. Biophysical Chemistry 54(3): 219-227
Qi, P.X.; Beckman, R.A.; Wand, A.J. 1996: Solution structure of horse heart ferricytochrome c and detection of redox-related structural changes by high-resolution 1H NMR. Biochemistry 35(38): 12275-12286
Qi, P.X.; Di Stefano, D.L.; Wand, A.J. 1994: Solution structure of horse heart ferrocytochrome c determined by high-resolution NMR and restrained simulated annealing. Biochemistry 33(21): 6408-6417
Motta, A.; Andreotti, G.; Amodeo, P.; Strazzullo, G.; Castiglione Morelli, M.A. 1998: Solution structure of human calcitonin in membrane-mimetic environment: The role of the amphipathic helix. Proteins 32(3): 314-323
Terasawa, H.; Kohda, D.; Hatanaka, H.; Nagata, K.; Higashihashi, N.; Fujiwara, H.; Sakano, K.; Inagaki, F. 1994: Solution structure of human insulin-like growth factor II; recognition sites for receptors and binding proteins. EMBO Journal 13(23): 5590-5597
Torres, A.M.; Forbes, B.E.; Aplin, S.E.; Wallace, J.C.; Francis, G.L.; Norton, R.S. 1995: Solution structure of human insulin-like growth factor II. Relationship to receptor and binding protein interactions. Journal of Molecular Biology 248(2): 385-401
Stockman, B.J.; Scahill, T.A.; Strakalaitis, N.A.; Brunner, D.P.; Yem, A.W.; Deibel, M.R. 1994: Solution structure of human interleukin-1 receptor antagonist protein. Febs Letters 349(1): 79-83
Zhang, F.; Lücke, C.; Baier, L.J.; Sacchettini, J.C.; Hamilton, J.A. 1997: Solution structure of human intestinal fatty acid binding protein: Implications for ligand entry and exit. Journal of Biomolecular NMR 9(3): 213-228
Lai, C.S.; Wolff, C.E.; Novello, D.; Griffone, L.; Cuniberti, C.; Molina, F.; Rocco, M. 1993: Solution structure of human plasma fibronectin under different solvent conditions. Fluorescence energy transfer, circular dichroism and light-scattering studies. Journal of Molecular Biology 230(2): 625-640
Moy, F.J.; Li, Y.C.; Rauenbuehler, P.; Winkler, M.E.; Scheraga, H.A.; Montelione, G.T. 1993: Solution structure of human type-alpha transforming growth factor determined by heteronuclear NMR spectroscopy and refined by energy minimization with restraints. Biochemistry 32(29): 7334-7353
Agback, P.; Sandström, A.; Yamakage, S.; Sund, C.; Glemarec, C.; Chattopadhyaya, J. 1993: Solution structure of lariat RNA by 500 MHz NMR spectroscopy and molecular dynamics studies in water. Journal of Biochemical and Biophysical Methods 27(3): 229-259
Hinds, M.G.; Maurer, T.; Zhang, J.G.; Nicola, N.A.; Norton, R.S. 1998: Solution structure of leukemia inhibitory factor. Journal of Biological Chemistry 273(22): 13738-13745
Hüttenhofer, A.; Westhof, E.; Böck, A. 1996: Solution structure of mRNA hairpins promoting selenocysteine incorporation in Escherichia coli and their base-specific interaction with special elongation factor SELB. Rna 2(4): 354-366
Watson, A.A.; Fairlie, D.P.; Craik, D.J. 1998: Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching?. Biochemistry 37(37): 12700-12706
Iwasaki, W.; Nagata, K.; Hatanaka, H.; Inui, T.; Kimura, T.; Muramatsu, T.; Yoshida, K.; Tasumi, M.; Inagaki, F. 1997: Solution structure of midkine, a new heparin-binding growth factor. EMBO Journal 16(23): 6936-6946
Sastry, M.; Fiala, R.; Patel, D.J. 1995: Solution structure of mithramycin dimers bound to partially overlapping sites on DNA. Journal of Molecular Biology 251(5): 674-689
Shao, W.; Jerva, L.F.; West, J.; Lolis, E.; Schweitzer, B.I. 1998: Solution structure of murine macrophage inflammatory protein-2. Biochemistry 37(23): 8303-8313
Labelle, M.; St-Pierre, S.; Savard, R.; Boulanger, Y. 1997: Solution structure of neuropeptide tyrosine 13-36, a Y2 receptor agonist, as determined by NMR. European Journal of Biochemistry 246(3): 780-785
Dardel, F.; Ragusa, S.; Lazennec, C.; Blanquet, S.; Meinnel, T. 1998: Solution structure of nickel-peptide deformylase. Journal of Molecular Biology 280(3): 501-513
Annila, A.; Lehtimäki, J.; Mattila, K.; Eriksson, J.E.; Sivonen, K.; Rantala, T.T.; Drakenberg, T. 1996: Solution structure of nodularin. An inhibitor of serine/threonine-specific protein phosphatases. Journal of Biological Chemistry 271(28): 16695-16702
Kim, J.K.; Soni, S.D.; Wallace, J.C.; Alderfer, J.L. 1993: Solution structure of nucleic acid photoadduct, deoxy-m5HO6-uridylyl(5-5)(3'-5')deoxyuridine by NMR and restrained molecular dynamics. Nucleic Acids Research 21(11): 2755-2759
Bornet, O.; Prévost, C.; Vovelle, F.; Chassignol, M.; Thuong, N.T.; Lancelot, G. 1995: Solution structure of oligonucleotides covalently linked to a psoralen derivative. Nucleic Acids Research 23(5): 788-795
Davis, J.H.; Bradley, E.K.; Miljanich, G.P.; Nadasdi, L.; Ramachandran, J.; Basus, V.J. 1993: Solution structure of omega-conotoxin GVIA using 2-D NMR spectroscopy and relaxation matrix analysis. Biochemistry 32(29): 7396-7405
Basus, V.J.; Nadasdi, L.; Ramachandran, J.; Miljanich, G.P. 1995: Solution structure of omega-conotoxin MVIIA using 2D NMR spectroscopy. Febs Letters 370(3): 163-169
Nemoto, N.; Kubo, S.; Yoshida, T.; Chino, N.; Kimura, T.; Sakakibara, S.; Kyogoku, Y.; Kobayashi, Y. 1995: Solution structure of omega-conotoxin MVIIC determined by NMR. Biochemical and Biophysical Research Communications 207(2): 695-700
Farr-Jones, S.; Miljanich, G.P.; Nadasdi, L.; Ramachandran, J.; Basus, V.J. 1995: Solution structure of omega-conotoxin MVIIC, a high affinity ligand of P-type calcium channels, using 1H NMR spectroscopy and complete relaxation matrix analysis. Journal of Molecular Biology 248(1): 106-124
Banci, L.; Bertini, I.; Bren, K.L.; Gray, H.B.; Sompornpisut, P.; Turano, P. 1997: Solution structure of oxidized Saccharomyces cerevisiae iso-1-cytochrome c. Biochemistry 36(29): 8992-9001
Banci, L.; Bertini, I.; De la Rosa, M.A.; Koulougliotis, D.; Navarro, J.A.; Walter, O. 1998: Solution structure of oxidized cytochrome c6 from the green alga Monoraphidium braunii. Biochemistry 37(14): 4831-4843
Banci, L.; Bertini, I.; Gray, H.B.; Luchinat, C.; Reddig, T.; Rosato, A.; Turano, P. 1997: Solution structure of oxidized horse heart cytochrome c. Biochemistry 36(32): 9867-9877
Barden, J., A.; Cuthbertson, R., M.; Wu-Jia-Zhen; Moseley, J., M.; Kemp, B., E. 1997: Solution structure of parathyroid hormone related protein (residues 1-34) containing an Ala substituted for an Ile in position 15 (PTHrP(Ala15)-(1-34)). Journal of Biological Chemistry 272(47): 29572-29578
Pieroni, O.; Fissi, A.; Pratesi, C.; Temussi, P.A.; Ciardelli, F. 1993: Solution structure of peptides containing two dehydro-phenylalanine residues: a CD investigation. Biopolymers 33(1): 1-10
Qian, H.; Edlund, U.; Powlowski, J.; Shingler, V.; Sethson, I. 1997: Solution structure of phenol hydroxylase protein component P2 determined by NMR spectroscopy. Biochemistry 36(3): 495-504
Wray, V.; Kakoschke, C.; Nokihara, K.; Naruse, S. 1993: Solution structure of pituitary adenylate cyclase activating polypeptide by nuclear magnetic resonance spectroscopy. Biochemistry 32(22): 5832-5841
Fushman, D.; Cahill, S.; Lemmon, M.A.; Schlessinger, J.; Cowburn, D. 1995: Solution structure of pleckstrin homology domain of dynamin by heteronuclear NMR spectroscopy. Proceedings of the National Academy of Sciences of the United States of America 92(3): 816-820
van den Berg, B.; Tessari, M.; Boelens, R.; Dijkman, R.; Kaptein, R.; de Haas, G.H.; Verheij, H.M. 1995: Solution structure of porcine pancreatic phospholipase A2 complexed with micelles and a competitive inhibitor. Journal of Biomolecular NMR 5(2): 110-121
van den Berg, B.; Tessari, M.; de Haas, G.H.; Verheij, H.M.; Boelens, R.; Kaptein, R. 1995: Solution structure of porcine pancreatic phospholipase A2. EMBO Journal 14(17): 4123-4131
Breg, J.N.; Sarda, L.; Cozzone, P.J.; Rugani, N.; Boelens, R.; Kaptein, R. 1995: Solution structure of porcine pancreatic procolipase as determined from 1H homonuclear two-dimensional and three-dimensional NMR. European Journal of Biochemistry 227(3): 663-672
Jaishree, T.N.; Ramakrishnan, V.; White, S.W. 1996: Solution structure of prokaryotic ribosomal protein S17 by high-resolution NMR spectroscopy. Biochemistry 35(9): 2845-2853
Fahrner, R.L.; Dieckmann, T.; Harwig, S.S.; Lehrer, R.I.; Eisenberg, D.; Feigon, J. 1996: Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chemistry and Biology 3(7): 543-550
Mohn, G.; Koehl, P.; Budzikiewicz, H.; Lefèvre, J.F. 1994: Solution structure of pyoverdin GM-II. Biochemistry 33(10): 2843-2851
Walkenhorst, W.F.; Krezel, A.M.; Rhyu, G.I.; Markley, J.L. 1994: Solution structure of reactive-site hydrolyzed turkey ovomucoid third domain by nuclear magnetic resonance and distance geometry methods. Journal of Molecular Biology 242(3): 215-230
Xu, G.Y.; Yu, H.A.; Hong, J.; Stahl, M.; McDonagh, T.; Kay, L.E.; Cumming, D.A. 1997: Solution structure of recombinant human interleukin-6. Journal of Molecular Biology 268(2): 468-481
Banci, L.; Benedetto, M.; Bertini, I.; Del Conte, R.; Piccioli, M.; Viezzoli, M.S. 1998: Solution structure of reduced monomeric Q133M2 copper, zinc superoxide dismutase (SOD). Why is SOD a dimeric enzyme?. Biochemistry 37(34): 11780-11791
Badsberg, U.; Jørgensen, A.M.; Gesmar, H.; Led, J.J.; Hammerstad, J.M.; Jespersen, L.L.; Ulstrup, J. 1996: Solution structure of reduced plastocyanin from the blue-green alga Anabaena variabilis. Biochemistry 35(22): 7021-7031
Dumy, P.; Eggleston, I.M.; Esposito, G.; Nicula, S.; Mutter, M. 1996: Solution structure of regioselectively addressable functionalized templates: an NMR and restrained molecular dynamics investigation. Biopolymers 39(3): 297-308
Talafous, J.; Marcinowski, K.J.; Klopman, G.; Zagorski, M.G. 1994: Solution structure of residues 1-28 of the amyloid beta-peptide. Biochemistry 33(25): 7788-7796
Baron, C.; Westhof, E.; Böck, A.; Giegé, R. 1993: Solution structure of selenocysteine-inserting tRNA(Sec) from Escherichia coli. Comparison with canonical tRNA(Ser). Journal of Molecular Biology 231(2): 274-292
Maurer, T.; Rüterjans, H. 1994: Solution structure of seminal plasmin in the presence of micelles. European Journal of Biochemistry 220(1): 111-116
Morton, C.J.; Simpson, R.J.; Norton, R.S. 1994: Solution structure of synthetic peptides corresponding to the C-terminal helix of interleukin-6. European Journal of Biochemistry 219(1-2): 97-107
Garrett, D.S.; Seok, Y.J.; Liao, D.I.; Peterkofsky, A.; Gronenborn, A.M.; Clore, G.M. 1997: Solution structure of the 30 kDa N-terminal domain of enzyme i of the Escherichia coli phosphoenolpyruvate:sugar phosphotransferase system by multidimensional NMR. Biochemistry 36(9): 2517-2530
Conte, M.R.; Lane, A.N.; Bloomberg, G. 1997: Solution structure of the ATF-2 recognition site and its interaction with the ATF-2 peptide. Nucleic Acids Research 25(19): 3808-3815
McIntosh, P.B.; Frenkiel, T.A.; Wollborn, U.; McCormick, J.E.; Klempnauer, K.H.; Feeney, J.; Carr, M.D. 1998: Solution structure of the B-Myb DNA-binding domain: a possible role for conformational instability of the protein in DNA binding and control of gene expression. Biochemistry 37(27): 9619-9629
Narula, S.S.; Yuan, R.W.; Adams, S.E.; Green, O.M.; Green, J.; Philips, T.B.; Zydowsky, L.D.; Botfield, M.C.; Hatada, M.; Laird, E.R. 1995: Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide. Structure 3(10): 1061-1073
Bagby, S.; Kim, S.; Maldonado, E.; Tong, K.I.; Reinberg, D.; Ikura, M. 1995: Solution structure of the C-terminal core domain of human TFIIB: Similarity to cyclin A and interaction with TATA-binding protein. Cell 82(5): 857-867
Yu, L.; Zhu, C.X.; Tse-Dinh, Y.C.; Fesik, S.W. 1995: Solution structure of the C-terminal single-stranded DNA-binding domain of Escherichia coli topoisomerase I. Biochemistry 34(23): 7622-7628
Jucker, F.M.; Pardi, A. 1995: Solution structure of the CUUG hairpin loop: A novel RNA tetraloop motif. Biochemistry 34(44): 14416-14427
Lodi, P.J.; Ernst, J.A.; Kuszewski, J.; Hickman, A.B.; Engelman, A.; Craigie, R.; Clore, G.M.; Gronenborn, A.M. 1995: Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry 34(31): 9826-9833
Shindo, H.; Iwaki, T.; Ieda, R.; Kurumizaka, H.; Ueguchi, C.; Mizuno, T.; Morikawa, S.; Nakamura, H.; Kuboniwa, H. 1995: Solution structure of the DNA binding domain of a nucleoid-associated protein, H-NS, from Escherichia coli. FEBS Letters 360(2): 125-131
Suzuki, M.; Neuhaus, D.; Gerstein, M.; Aimoto, S. 1994: Solution structure of the DNA binding octapeptide repeat of the K10 gene product. Protein Engineering 7(4): 461-470
Myers, L.C.; Verdine, G.L.; Wagner, G. 1993: Solution structure of the DNA methyl phosphotriester repair domain of Escherichia coli Ada. Biochemistry 32(51): 14089-14094
Ikegami, T.; Kuraoka, I.; Saijo, M.; Kodo, N.; Kyogoku, Y.; Morikawa, K.; Tanaka, K.; Shirakawa, M. 1998: Solution structure of the DNA-and RPA-binding domain of the human repair factor XPA. Nature Structural Biology 5(8): 701-706
Sunnerhagen, M.; Nilges, M.; Otting, G.; Carey, J. 1997: Solution structure of the DNA-binding domain and model for the complex of multifunctional hexameric arginine repressor with DNA. Nature Structural Biology 4(10): 819-826
Liang, H.; Petros, A.M.; Meadows, R.P.; Yoon, H.S.; Egan, D.A.; Walter, K.; Holzman, T.F.; Robins, T.; Fesik, S.W. 1996: Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: evidence for flexible DNA-binding regions. Biochemistry 35(7): 2095-2103
Nishikawa, T.; Nagadoi, A.; Yoshimura, S.; Aimoto, S.; Nishimura, Y. 1998: Solution structure of the DNA-binding domain of human telomeric protein, hTRF1. Structure 6(8): 1057-1065
Damberger, F.F.; Pelton, J.G.; Harrison, C.J.; Nelson, H.C.; Wemmer, D.E. 1994: Solution structure of the DNA-binding domain of the heat shock transcription factor determined by multidimensional heteronuclear magnetic resonance spectroscopy. Protein Science: a Publication of the Protein Society 3(10): 1806-1821
Edmondson, S.P.; Qiu, L.; Shriver, J.W. 1995: Solution structure of the DNA-binding protein Sac7d from the hyperthermophile Sulfolobus acidocaldarius. Biochemistry 34(41): 13289-13304
Starovasnik, M.A.; Skelton, N.J.; O'Connell, M.P.; Kelley, R.F.; Reilly, D.; Fairbrother, W.J. 1996: Solution structure of the E-domain of staphylococcal protein a. Biochemistry 35(48): 15558-15569
Donaldson, L.W.; Petersen, J.M.; Graves, B.J.; McIntosh, L.P. 1996: Solution structure of the ETS domain from murine Ets-1: a winged helix-turn-helix DNA binding motif. EMBO Journal 15(1): 125-134
Wittekind, M.; Mapelli, C.; Lee, V.; Goldfarb, V.; Friedrichs, M.S.; Meyers, C.A.; Mueller, L. 1997: Solution structure of the Grb2 N-terminal SH3 domain complexed with a ten-residue peptide derived from SOS: direct refinement against NOEs, J-couplings and 1H and 13C chemical shifts. Journal of Molecular Biology 267(4): 933-952
van Boulanger, Y.; Senécal, L.; Sauvé, G. 1997: Solution structure of the HIV protease inhibitor acetyl-pepstatin as determined by NMR and molecular modeling. Journal of Biomolecular Structure and Dynamics 14(4): 421-428
Vis, H.; Mariani, M.; Vorgias, C.E.; Wilson, K.S.; Kaptein, R.; Boelens, R. 1995: Solution structure of the HU protein from Bacillus stearothermophilus. Journal of Molecular Biology 254(4): 692-703
Eberstadt, M.; Grdadolnik, S.G.; Gemmecker, G.; Kessler, H.; Buhr, A.; Erni, B. 1996: Solution structure of the IIB domain of the glucose transporter of Escherichia coli. Biochemistry 35(35): 11286-11292
Furui, J.; Uegaki, K.; Yamazaki, T.; Shirakawa, M.; Swindells, M.B.; Harada, H.; Taniguchi, T.; Kyogoku, Y. 1998: Solution structure of the IRF-2 DNA-binding domain: A novel subgroup of the winged helix-turn-helix family. Structure 6(4): 491-500
Fogh, R.H.; Ottleben, G.; Rüterjans, H.; Schnarr, M.; Boelens, R.; Kaptein, R. 1994: Solution structure of the LexA repressor DNA binding domain determined by 1H NMR spectroscopy. EMBO Journal 13(17): 3936-3944
Papavoine, C.H.; Christiaans, B.E.; Folmer, R.H.; Konings, R.N.; Hilbers, C.W. 1998: Solution structure of the M13 major coat protein in detergent micelles: a basis for a model of phage assembly involving specific residues. Journal of Molecular Biology 282(2): 401-419
Schumacher, S.; Clubb, R.T.; Cai, M.; Mizuuchi, K.; Clore, G.M.; Gronenborn, A.M. 1997: Solution structure of the Mu end DNA-binding ibeta subdomain of phage Mu transposase: modular DNA recognition by two tethered domains. EMBO Journal 16(24): 7532-7541
Abeygunawardana, C.; Weber, D.J.; Gittis, A.G.; Frick, D.N.; Lin, J.; Miller, A.F.; Bessman, M.J.; Mildvan, A.S. 1995: Solution structure of the MutT enzyme, a nucleoside triphosphate pyrophosphohydrolase. Biochemistry 34(46): 14997-15005
Muranyi, A.; Finn, B.E.; Gippert, G.P.; Forsén, S.; Stenflo, J.; Drakenberg, T. 1998: Solution structure of the N-terminal EGF-like domain from human factor VIi. Biochemistry 37(30): 10605-10615
Avis, J.M.; Allain, F.H.; Howe, P.W.; Varani, G.; Nagai, K.; Neuhaus, D. 1996: Solution structure of the N-terminal RNP domain of U1A protein: the role of C-terminal residues in structure stability and RNA binding. Journal of Molecular Biology 257(2): 398-411
Cox, M.; van Tilborg, P.J.; de Laat, W.; Boelens, R.; van Leeuwen, H.C.; van der Vliet, P.C.; Kaptein, R. 1995: Solution structure of the Oct-1 POU homeodomain determined by NMR and restrained molecular dynamics. Journal of Biomolecular NMR 6(1): 23-32
Dekker, N.; Cox, M.; Boelens, R.; Verrijzer, C.P.; Van Der Vliet, P.C.; Kaptein, R. 1993: Solution structure of the POU-specfic DNA-binding domain of Oct-1. Nature (London) 362(6423): 852-855
Chou, J.J.; Matsuo, H.; Duan, H.; Wagner, G. 1998: Solution structure of the RAIDD CARD and model for CARD/CARD interaction in Caspase-2 and Caspase-9 recruitment. Cell 94(2): 171-180
Hansson, H.; Mattsson, P.T.; Allard, P.; Haapaniemi, P.; Vihinen, M.; Smith, C.I.; Hard, T. 1998: Solution structure of the SH3 domain from Bruton's tyrosine kinase. Biochemistry 37(9): 2912-2924
Yu, H.; Rosen, M.K.; Shin, T.B.; Seidel-Dugan, C.; Brugge, J.S.; Schreiber, S.L. 1992: Solution structure of the SH3 domain of Src and identification of its ligand-binding site. Science 258(5088): 1665-1668
Kohda, D.; Hatanaka, H.; Odaka, M.; Mandiyan, V.; Ullrich, A.; Schlessinger, J.; Inagaki, F. 1993: Solution structure of the SH3 domain of phospholipase C-gamma. Cell 72(6): 953-960
Zhou, M.M.; Meadows, R.P.; Logan, T.M.; Yoon, H.S.; Wade, W.S.; Ravichandran, K.S.; Burakoff, S.J.; Fesik, S.W. 1995: Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor. Proceedings of the National Academy of Sciences of the United States of America 92(17): 7784-7788
Kim, S.G.; Reid, B.R. 1992: Solution structure of the TnAn DNA duplex GCCGTTAACGCG containing the HpaI restriction site. Biochemistry 31(48): 12103-12116
Findlay, W.A.; Sönnichsen, F.D.; Sykes, B.D. 1994: Solution structure of the TR1C fragment of skeletal muscle troponin-C. Journal of Biological Chemistry 269(9): 6773-6778
Wang, Y.; Patel, D.J. 1994: Solution structure of the Tetrahymena telomeric repeat d(T2G4)4 G-tetraplex. Structure 2(12): 1141-1156
Gupta, G.; Anantharamaiah, G.M.; Scott, D.R.; Eldridge, J.H.; Myers, G. 1993: Solution structure of the V3 loop of a Thailand HIV isolate. Journal of Biomolecular Structure and Dynamics 11(2): 345-366
Jarvis, J.A.; Ryan, M.T.; Hoogenraad, N.J.; Craik, D.J.; Høj, P.B. 1995: Solution structure of the acetylated and noncleavable mitochondrial targeting signal of rat chaperonin 10. Journal of Biological Chemistry 270(3): 1323-1331
Crump, M.P.; Crosby, J.; Dempsey, C.E.; Parkinson, J.A.; Murray, M.; Hopwood, D.A.; Simpson, T.J. 1997: Solution structure of the actinorhodin polyketide synthase acyl carrier protein from Streptomyces coelicolor A3(2). Biochemistry 36(20): 6000-6008
Jeon, Y.H.; Negishi, T.; Shirakawa, M.; Yamazaki, T.; Fujita, N.; Ishihama, A.; Kyogoku, Y. 1995: Solution structure of the activator contact domain of the RNA polymerase alpha subunit. Science 270(5241): 1495-1497
Williamson, R.A.; Martorell, G.; Carr, M.D.; Murphy, G.; Docherty, A.J.; Freedman, R.B.; Feeney, J. 1994: Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family. Biochemistry 33(39): 11745-11759
Johansson, M.U.; de Château, M.; Wikström, M.; Forsén, S.; Drakenberg, T.; Björck, L. 1997: Solution structure of the albumin-binding GA module: a versatile bacterial protein domain. Journal of Molecular Biology 266(5): 859-865
Hansen, A.P.; Petros, A.M.; Meadows, R.P.; Nettesheim, D.G.; Mazar, A.P.; Olejniczak, E.T.; Xu, R.X.; Pederson, T.M.; Henkin, J.; Fesik, S.W. 1994: Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator. Biochemistry 33(16): 4847-4864
Commans, S.; Plateau, P.; Blanquet, S.; Dardel, F. 1995: Solution structure of the anticodon-binding domain of Escherichia coli lysyl-tRNA synthetase and studies of its interaction with tRNA(Lys). Journal of Molecular Biology 253(1): 100-113
Vignal, E.; Chavanieu, A.; Roch, P.; Chiche, L.; Grassy, G.; Calas, B.; Aumelas, A. 1998: Solution structure of the antimicrobial peptide ranalexin and a study of its interaction with perdeuterated dodecylphosphocholine micelles. European Journal of Biochemistry 253(1): 221-228
Huenges, M.; Rölz, C.; Gschwind, R.; Peteranderl, R.; Berglechner, F.; Richter, G.; Bacher, A.; Kessler, H.; Gemmecker, G. 1998: Solution structure of the antitermination protein NusB of Escherichia coli: a novel all-helical fold for an RNA-binding protein. EMBO Journal 17(14): 4092-4100
Olah, G.A.; Mitchell, R.D.; Sosnick, T.R.; Walsh, D.A.; Trewhella, J. 1993: Solution structure of the cAMP-dependent protein kinase catalytic subunit and its contraction upon binding the protein kinase inhibitor peptide. Biochemistry 32(14): 3649-3657
Konrat, R.; Weiskirchen, R.; Kräutler, B.; Bister, K. 1997: Solution structure of the carboxyl-terminal LIM domain from quail cysteine-rich protein CRP2. Journal of Biological Chemistry 272(18): 12001-12007
Monks, S.A.; Pallaghy, P.K.; Scanlon, M.J.; Norton, R.S. 1995: Solution structure of the cardiostimulant polypeptide anthopleurin-B and comparison with anthopleurin-A. Structure 3(8): 791-803
Van Doren, S.R.; Kurochkin, A.V.; Hu, W.; Ye, Q.Z.; Johnson, L.L.; Hupe, D.J.; Zuiderweg, E.R. 1995: Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor. Protein Science: a Publication of the Protein Society 4(12): 2487-2498
Li, Y.C.; Zhang, X.; Melton, R.; Ganu, V.; Gonnella, N.C. 1998: Solution structure of the catalytic domain of human stromelysin-1 complexed to a potent, nonpeptidic inhibitor. Biochemistry 37(40): 14048-14056
Mattinen, M.L.; Linder, M.; Drakenberg, T.; Annila, A. 1998: Solution structure of the cellulose-binding domain of endoglucanase I from Trichoderma reesei and its interaction with cello-oligosaccharides. European Journal of Biochemistry 256(2): 279-286
Brun, E.; Moriaud, F.; Gans, P.; Blackledge, M.J.; Barras, F.; Marion, D. 1997: Solution structure of the cellulose-binding domain of the endoglucanase Z secreted by Erwinia chrysanthemi. Biochemistry 36(51): 16074-16086
Butcher, S.E.; Dieckmann, T.; Feigon, J. 1997: Solution structure of the conserved 16 S-like ribosomal RNA UGAA tetraloop. Journal of Molecular Biology 268(2): 348-358
Radha, P.K.; Madan, A.; Nibedita, R.; Hosur, R.V. 1995: Solution structure of the conserved segment of the Myb cognate DNA sequence by 2D NMR, spectral simulation, restrained energy minimization, and distance geometry calculations. Biochemistry 34(17): 5913-5922
Zhou, P.; Sun, L.J.; Dötsch, V.; Wagner, G.; Verdine, G.L. 1998: Solution structure of the core NFATC1/DNA complex. Cell 92(5): 687-696
Lin, C.H.; Patel, D.J. 1995: Solution structure of the covalent duocarmycin A-DNA duplex complex. Journal of Molecular Biology 248(1): 162-179
Betz, S.F.; Schnuchel, A.; Wang, H.; Olejniczak, E.T.; Meadows, R.P.; Lipsky, B.P.; Harris, E.A.; Staunton, D.E.; Fesik, S.W. 1998: Solution structure of the cytohesin-1 (B2-1) Sec7 domain and its interaction with the GTPase ADP ribosylation factor 1. Proceedings of the National Academy of Sciences of the United States of America 95(14): 7909-7914
Mortishire-Smith, R.J.; Pitzenberger, S.M.; Burke, C.J.; Middaugh, C.R.; Garsky, V.M.; Johnson, R.G. 1995: Solution structure of the cytoplasmic domain of phopholamban: phosphorylation leads to a local perturbation in secondary structure. Biochemistry 34(23): 7603-7613
Federau, T.; Schubert, U.; Flossdorf, J.; Henklein, P.; Schomburg, D.; Wray, V. 1996: Solution structure of the cytoplasmic domain of the human immunodeficiency virus type 1 encoded virus protein U (Vpu). International Journal of Peptide and Protein Research 47(4): 297-310
Greenbaum, N.L.; Radhakrishnan, I.; Patel, D.J.; Hirsh, D. 1996: Solution structure of the donor site of a trans-splicing RNA. Structure 4(6): 725-733
Bersch, B.; Hernandez, J.F.; Marion, D.; Arlaud, G.J. 1998: Solution structure of the epidermal growth factor (EGF)-like module of human complement protease C1r, an atypical member of the EGF family. Biochemistry 37(5): 1204-1214
Nagata, K.; Kohda, D.; Hatanaka, H.; Ichikawa, S.; Matsuda, S.; Yamamoto, T.; Suzuki, A.; Inagaki, F. 1994: Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4. EMBO Journal 13(15): 3517-3523
Overduin, M.; Harvey, T.S.; Bagby, S.; Tong, K.I.; Yau, P.; Takeichi, M.; Ikura, M. 1995: Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science 267(5196): 386-389
Wilkens, S.; Capaldi, R.A. 1998: Solution structure of the epsilon subunit of the F1-ATPase from Escherichia coli and interactions of this subunit with beta subunits in the complex. Journal of Biological Chemistry 273(41): 26645-26651
Rejante, M.R.; Llinás, M. 1994: Solution structure of the epsilon-aminohexanoic acid complex of human plasminogen kringle 1. European Journal of Biochemistry 221(3): 939-949
Kumar, R.A.; Ikemoto, N.; Patel, D.J. 1997: Solution structure of the esperamicin A1-DNA complex. Journal of Molecular Biology 265(2): 173-186
Huang, P.; Patel, D.J.; Eisenberg, M. 1993: Solution structure of the exocyclic 1,N2-propanodeoxyguanosine adduct opposite deoxyadenosine in a DNA nonamer duplex at pH 8.9. model of pH-dependent conformational transition. Biochemistry 32(15): 3852-3866
Wuttke, D.S.; Foster, M.P.; Case, D.A.; Gottesfeld, J.M.; Wright, P.E. 1997: Solution structure of the first three zinc fingers of TFIIIA bound to the cognate DNA sequence: determinants of affinity and sequence specificity. Journal of Molecular Biology 273(1): 183-206
Sticht, H.; Pickford, A.R.; Potts, J.R.; Campbell, I.D. 1998: Solution structure of the glycosylated second type 2 module of fibronectin. Journal of Molecular Biology 276(1): 177-187
Sorimachi, K.; Le Gal-Coëffet, M.F.; Williamson, G.; Archer, D.B.; Williamson, M.P. 1997: Solution structure of the granular starch binding domain of Aspergillus niger glucoamylase bound to beta-cyclodextrin. Structure 5(5): 647-661
Sorimachi, K.; Jacks, A.J.; Le Gal-Coëffet, M.F.; Williamson, G.; Archer, D.B.; Williamson, M.P. 1996: Solution structure of the granular starch binding domain of glucoamylase from Aspergillus niger by nuclear magnetic resonance spectroscopy. Journal of Molecular Biology 259(5): 970-987
Fairbrother, W.J.; Champe, M.A.; Christinger, H.W.; Keyt, B.A.; Starovasnik, M.A. 1998: Solution structure of the heparin-binding domain of vascular endothelial growth factor. Structure 6(5): 637-648
Willbold, D..; Rösch, P.. 1996: Solution structure of the human CD4 (403-419) receptor peptide. Journal of Biomedical Science 3(6): 435-441
Horita, D.A.; Baldisseri, D.M.; Zhang, W.; Altieri, A.S.; Smithgall, T.E.; Gmeiner, W.H.; Byrd, R.A. 1998: Solution structure of the human Hck SH3 domain and identification of its ligand binding site. Journal of Molecular Biology 278(1): 253-265
Xu, R.X.; Word, J.M.; Davis, D.G.; Rink, M.J.; Willard, D.H.; Gampe, R.T. 1995: Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide. Biochemistry 34(7): 2107-2121
Wray, V.; Federau, T.; Henklein, P.; Klabunde, S.; Kunert, O.; Schomburg, D.; Schubert, U. 1995: Solution structure of the hydrophilic region of HIV-1 encoded virus protein U (Vpu) by CD and 1H NMR spectroscopy. International Journal of Peptide and Protein Research 45(1): 35-43
Doreleijers, J.F.; Langedijk, J.P.; Hård, K.; Boelens, R.; Rullmann, J.A.; Schaaper, W.M.; van Oirschot, J.T.; Kaptein, R. 1996: Solution structure of the immunodominant region of protein G of bovine respiratory syncytial virus. Biochemistry 35(47): 14684-14688
Li, X.; Bokman, A.M.; Llinás, M.; Smith, R.A.; Dobson, C.M. 1994: Solution structure of the kringle domain from urokinase-type plasminogen activator. Journal of Molecular Biology 235(5): 1548-1559
Kohda, D.; Morton, C.J.; Parkar, A.A.; Hatanaka, H.; Inagaki, F.M.; Campbell, I.D.; Day, A.J. 1996: Solution structure of the link module: A hyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell 86(5): 767-775
Berg, A.; Vervoort, J.; de Kok, A. 1996: Solution structure of the lipoyl domain of the 2-oxoglutarate dehydrogenase complex from Azotobacter vinelandii. Journal of Molecular Biology 261(3): 432-442
Sastry, M.; Patel, D.J. 1993: Solution structure of the mithramycin dimer-DNA complex. Biochemistry 32(26): 6588-6604
Sastry, M.; Fiala, R.; Lipman, R.; Tomasz, M.; Patel, D.J. 1995: Solution structure of the monoalkylated mitomycin C-DNA complex. Journal of Molecular Biology 247(2): 338-359
Katahira, R.; Katahira, M.; Yamashita, Y.; Ogawa, H.; Kyogoku, Y.; Yoshida, M. 1998: Solution structure of the novel antitumor drug UCH9 complexed with d(TTGGCCAA)2 as determined by NMR. Nucleic Acids Research 26(3): 744-755
Aono, S.; Bentrop, D.; Bertini, I.; Donaire, A.; Luchinat, C.; Niikura, Y.; Rosato, A. 1998: Solution structure of the oxidized Fe7S8 ferredoxin from the thermophilic bacterium Bacillus schlegelii by 1H NMR spectroscopy. Biochemistry 37(27): 9812-9826
Bentrop, D.; Bertini, I.; Cremonini, M.A.; Forsén, S.; Luchinat, C.; Malmendal, A. 1997: Solution structure of the paramagnetic complex of the N-terminal domain of calmodulin with two Ce3+ ions by 1H NMR. Biochemistry 36(39): 11605-11618
Wittekind, M.; Rajagopal, P.; Branchini, B.R.; Reizer, J.; Saier, M.H.; Klevit, R.E. 1992: Solution structure of the phosphocarrier protein HPr from Bacillus subtilis by two-dimensional NMR spectroscopy. Protein Science: a Publication of the Protein Society 1(10): 1363-1376
Katahira, R.; Flotow, H.; Thomas, G.; Nosaka, A.Y. 1996: Solution structure of the phosphorylated sites of ribosomal protein S6 by 1H NMR spectroscopy. International Journal of Peptide and Protein Research 47(4): 282-288
Zhang, P.; Talluri, S.; Deng, H.; Branton, D.; Wagner, G. 1995: Solution structure of the pleckstrin homology domain of Drosophila beta-spectrin. Structure 3(11): 1185-1195
Krezel, A.M.; Kasibhatla, C.; Hidalgo, P.; MacKinnon, R.; Wagner, G. 1995: Solution structure of the potassium channel inhibitor agitoxin 2: caliper for probing channel geometry. Protein Science: a Publication of the Protein Society 4(8): 1478-1489
Lin, J.; Abeygunawardana, C.; Frick, D.N.; Bessman, M.J.; Mildvan, A.S. 1997: Solution structure of the quaternary MutT-M2+-AMPCPP-M2+ complex and mechanism of its pyrophosphohydrolase action. Biochemistry 36(6): 1199-1211
Emerson, S.D.; Madison, V.S.; Palermo, R.E.; Waugh, D.S.; Scheffler, J.E.; Tsao, K.L.; Kiefer, S.E.; Liu, S.P.; Fry, D.C. 1995: Solution structure of the ras-binding domain of c-Raf-1 and identification of its Ras interaction surface. Biochemistry 34(21): 6911-6918
Yang, Y.S.; Guignard, L.; Padilla, A.; Hoh, F.; Strub, M.P.; Stern, M.H.; Lhoste, J.M.; Roumestand, C. 1998: Solution structure of the recombinant human oncoprotein p13MTCP1. Journal of Biomolecular NMR 11(3): 337-354
Garcia, C.; Fortier, P.L.; Blanquet, S.; Lallemand, J.Y.; Dardel, F. 1995: Solution structure of the ribosome-binding domain of E. coli translation initiation factor IF3. Homology with the U1A protein of the eukaryotic spliceosome. Journal of Molecular Biology 254(2): 247-259
Folmer, R.H.; Nilges, M.; Konings, R.N.; Hilbers, C.W. 1995: Solution structure of the single-stranded DNA binding protein of the filamentous Pseudomonas phage Pf3: similarity to other proteins binding to single-stranded nucleic acids. EMBO Journal 14(17): 4132-4142
Hill, J.M.; Alewood, P.F.; Craik, D.J. 1997: Solution structure of the sodium channel antagonist conotoxin GS: A new molecular caliper for probing sodium channel geometry. Structure 5(4): 571-583
Pascual, J.; Pfuhl, M.; Walther, D.; Saraste, M.; Nilges, M. 1997: Solution structure of the spectrin repeat: a left-handed antiparallel triple-helical coiled-coil. Journal of Molecular Biology 273(3): 740-751
Bilgin, N.; Ehrenberg, M.; Ebel, C.; Zaccai, G.; Sayers, Z.; Koch, M.H.; Svergun, D.I.; Barberato, C.; Volkov, V.; Nissen, P.; Nyborg, J. 1998: Solution structure of the ternary complex between aminoacyl-tRNA, elongation factor Tu, and guanosine triphosphate. Biochemistry 37(22): 8163-8172
Daly, N.L.; Atkins, A.R.; Smith, R. 1993: Solution structure of the toxic octapeptide, lophyrotomin. International Journal of Peptide and Protein Research 42(4): 366-371
Girvin, M.E.; Rastogi, V.K.; Abildgaard, F.; Markley, J.L.; Fillingame, R.H. 1998: Solution structure of the transmembrane H+-transporting subunit c of the F1F0 ATP synthase. Biochemistry 37(25): 8817-8824
Kalverda, A.P.; Wymenga, S.S.; Lommen, A.; van de Ven, F.J.; Hilbers, C.W.; Canters, G.W. 1994: Solution structure of the type 1 blue copper protein amicyanin from Thiobacillus versutus. Journal of Molecular Biology 240(4): 358-371
Ohyama, Y.; Sodano, P.; Locker, D.; Bianchi, M.E.; Leng, M.; Vovelle, F.; Ptak, M. 1997: Solution structure of the wild-type HMG1 A box by 1H and 15N NMR and molecular modelling. Protein and Peptide Letters 4(2): 107-114
Hasegawa, J.; Yoshida, T.; Yamazaki, T.; Sambongi, Y.; Yu, Y.; Igarashi, Y.; Kodama, T.; Yamazaki, K.; Kyogoku, Y.; Kobayashi, Y. 1998: Solution structure of thermostable cytochrome c-552 from Hydrogenobacter thermophilus determined by 1H-NMR spectroscopy. Biochemistry 37(27): 9641-9649
Curto, E.V.; Jarpe, M.A.; Blalock, J.E.; Borovsky, D.; Krishna, N.R. 1993: Solution structure of trypsin modulating oostatic factor is a left-handed helix. Biochemical and Biophysical Research Communications 193(2): 688-693
Krezel, A.M.; Darba, P.; Robertson, A.D.; Fejzo, J.; Macura, S.; Markley, J.L. 1994: Solution structure of turkey ovomucoid third domain as determined from nuclear magnetic resonance data. Journal of Molecular Biology 242(3): 203-214
Haghjoo, K.; Cash, P.W.; Farid, R.S.; Komisaruk, B.R.; Jordan, F.; Pochapsky, S.S. 1996: Solution structure of vasoactive intestinal polypeptide (11-28)-NH2, a fragment with analgesic properties. Peptide Research 9(6): 327-331
Markus, M.A.; Nakayama, T.; Matsudaira, P.; Wagner, G. 1994: Solution structure of villin 14T, a domain conserved among actin-severing proteins. Protein Science: a Publication of the Protein Society 3(1): 70-81
Kovacs, H.; Comfort, D.; Lord, M.; Campbell, I.D.; Yudkin, M.D. 1998: Solution structure of SpoIIAA, a phosphorylatable component of the system that regulates transcription factor sigmaF of Bacillus subtilis. Proceedings of the National Academy of Sciences of the United States of America 95(9): 5067-5071
Yang, Y.; Huang, L.; Pon, R.T.; Cheng, S.F.; Chang, D.K.; Lown, J.W. 1996: Solution structure studies of the cobalt complex of a bleomycin functional model bound to d(CGCAATTGCG)2 by two-dimensional nuclear magnetic resonance methods and restrained molecular dynamics simulation. Bioconjugate Chemistry 7(6): 670-679
Cordier, F.; Caffrey, M.; Brutscher, B.; Cusanovich, M.A.; Marion, D.; Blackledge, M. 1998: Solution structure, rotational diffusion anisotropy and local backbone dynamics of Rhodobacter capsulatus cytochrome c2. Journal of Molecular Biology 281(2): 341-361
Sahasrabudhe, P.V.; Pon, R.T.; Gmeiner, W.H. 1996: Solution structures of 5-fluorouracil-substituted DNA and RNA decamer duplexes. Biochemistry 35(42): 13597-13608
Sahasrabudhe, P.V.; Gmeiner, W.H. 1997: Solution structures of 5-fluorouracil-substituted RNA duplexes containing G-U wobble base pairs. Biochemistry 36(20): 5981-5991
Thiyagarajan, P.; Henderson, S.J.; Joachimiak, A. 1996: Solution structures of GroEL and its complex with rhodanese from small-angle neutron scattering. Structure 4(1): 79-88
Tugarinov, V.; Kustanovich, I.; Zilberberg, N.; Gurevitz, M.; Anglister, J. 1997: Solution structures of a highly insecticidal recombinant scorpion alpha-toxin and a mutant with increased activity. Biochemistry 36(9): 2414-2424
Sudmeier, J.L.; Günther, U.L.; Gutheil, W.G.; Coutts, S.J.; Snow, R.J.; Barton, R.W.; Bachovchin, W.W. 1994: Solution structures of active and inactive forms of the DP IV (CD26) inhibitor Pro-boroPro determined by NMR spectroscopy. Biochemistry 33(41): 12427-12438
Clish, C.B.; Peyton, D.H.; Barklis, E. 1998: Solution structures of human immunodeficiency virus type 1 (HIV-1) and moloney murine leukemia virus (MoMLV) capsid protein major-homology-region peptide analogs by NMR spectroscopy. European Journal of Biochemistry 257(1): 69-77
Spielmann, H.P.; Dwyer, T.J.; Hearst, J.E.; Wemmer, D.E. 1995: Solution structures of psoralen monoadducted and cross-linked DNA oligomers by NMR spectroscopy and restrained molecular dynamics. Biochemistry 34(40): 12937-12953
Jankowsky, R.; Kirsch, S.; Reich, T.; Speis, H.; Johannsen, B. 1998: Solution structures of rhenium (V) oxo peptide complexes of glycylglycylcysteine and cysteinylglycine as studied by capillary electrophoresis and X-ray absorption spectroscopy. Journal of Inorganic Biochemistry 70(2): 99-106
Wang, J.; Truckses, D.M.; Abildgaard, F.; Dzakula, Z.; Zolnai, Z.; Markley, J.L. 1997: Solution structures of staphylococcal nuclease from multidimensional, multinuclear NMR: nuclease-H124L and its ternary complex with Ca2+ and thymidine-3',5'-bisphosphate. Journal of Biomolecular NMR 10(2): 143-164
Mariappan, S.V.; Silks, L.A.; Chen, X.; Springer, P.A.; Wu, R.; Moyzis, R.K.; Bradbury, E.M.; Garcia, A.E.; Gupta, G. 1998: Solution structures of the Huntington's disease DNA triplets, (CAG)n. Journal of Biomolecular Structure and Dynamics 15(4): 723-744
Chang, X.; Jorgensen, A.M.; Bardrum, P.; Led, J.J. 1997: Solution structures of the R6 human insulin hexamer,. Biochemistry 36(31): 9409-9422
Leroy, J.L.; Guéron, M. 1995: Solution structures of the i-motif tetramers of d(TCC), d(5methylCCT) and d(T5methylCC): Novel NOE connections between amino protons and sugar protons. Structure 3(1): 101-120
Zimmermann, N.; Freund, S.; Fredenhagen, A.; Jung, G. 1993: Solution structures of the lantibiotics duramycin B and C. European Journal of Biochemistry 216(2): 419-428
Lee, J.H.; Lim, S.K.; Huh, S.H.; Lee, D.; Lee, W. 1998: Solution structures of the melanocyte-stimulating hormones by two-dimensional NMR spectroscopy and dynamical simulated-annealing calculations. European Journal of Biochemistry 257(1): 31-40
Smith, F.W.; Schultze, P.; Feigon, J. 1995: Solution structures of unimolecular quadruplexes formed by oligonucleotides containing Oxytricha telomere repeats. Structure 3(10): 997-1008
DiGiammarino, E.L.; Draker, K.A.; Wright, G.D.; Serpersu, E.H. 1998: Solution studies of isepamicin and conformational comparisons between isepamicin and butirosin A when bound to an aminoglycoside 6'-N-acetyltransferase determined by NMR spectroscopy. Biochemistry 37(11): 3638-3644
Pintar, A.; Hensmann, M.; Jumel, K.; Pitkeathly, M.; Harding, S.E.; Campbell, I.D. 1996: Solution studies of the SH2 domain from the fyn tyrosine kinase: Secondary structure, backbone dynamics and protein association. European Biophysics Journal: Ebj 24(6): 371-380
Gonzalez Vilchez, F.; Vilaplana, R.; Blasco, G.; Messori, L. 1998: Solution studies of the antitumor complex dichloro 1,2-propylendiaminetetraacetate ruthenium (III) and of its interactions with proteins. Journal of Inorganic Biochemistry 71(1-2): 45-51
Kuroda, H.; Chen, Y.N.; Watanabe, T.X.; Kimura, T.; Sakakibara, S. 1992: Solution synthesis of calciseptine, an L-type specific calcium channel blocker. Peptide Research 5(5): 265-268
Kubo, S.; Chino, N.; Watanabe, T.X.; Kimura, T.; Sakakibara, S. 1993: Solution synthesis of mu-conotoxin GIIIB: optimization of the oxidative folding reaction. Peptide Research 6(2): 66-72
Bonmatin, J.M.; Genest, M.; Labbé, H.; Ptak, M. 1994: Solution three-dimensional structure of surfactin: a cyclic lipopeptide studied by 1H-NMR, distance geometry, and molecular dynamics. Biopolymers 34(7): 975-986
Carriere, C.J.; Inglett, G.E. 1998: Solution viscoelastic properties of OATRIM-10 and cooked oat bran. Cereal Chemistry 75(3): 354-359
Reddy, I.M.; Mahoney, A., W. 1995: Solution visible difference spectral properties of Fe-3+-L-amino acid complexes at pH 6.60. Journal of Agricultural and Food Chemistry 43(6): 1436-1443
Glaser, R.; Geresh, S.; Blumenfeld, J.; Donnell, D.; Sugisaka, N.; Drouin, M.; Michel, A. 1993: Solution- and solid-state structures of N-desmethylnefopam hydrochloride, a metabolite of the analgesic drug. Journal of Pharmaceutical Sciences 82(3): 276-281
Myatt, E.A.; Stevens, F.J.; Benjamin, C. 1994: Solution-phase binding of monoclonal antibodies to bee venom phospholipase A2. Journal of Immunological Methods 177(1-2): 35-42
Boger, D.L.; Chai, W.; Ozer, R.S.; Andersson, C.M.gnus 1997: Solution-phase combinatorial synthesis via the olefin metathesis reaction. Bioorganic and Medicinal Chemistry Letters 7(4): 463-468
Boger, D., L.; Chai, W. 1998: Solution-phase combinatorial synthesis: Convergent multiplication of diversity via the olefin metathesis reaction. Tetrahedron 54(16): 3955-3970
Schmalzing, D.; Nashabeh, W.; Fuchs, M. 1995: Solution-phase immunoassay for determination of cortisol in serum by capillary electrophoresis. Clinical Chemistry 41(9): 1403-1406
Gayo, L.M. 1998: Solution-phase library generation: Methods and applications in drug discovery. Biotechnology and Bioengineering 61(2): 95-106
Buckman, B.O.; Morrissey, M.M.; Mohan, R. 1998: Solution-phase parallel synthesis of benzoxazines using a polymer-supported carbodiimide. Tetrahedron Letters 39(12): 1487-1488
Kane, R.R.; Pak, R.H.; Hawthorne, M.F.ederick 1993: Solution-phase segment synthesis of boron-rich peptides. Journal of Organic Chemistry 58(5): 991-992
Fiorini, M.T.; Abell, C. 1998: Solution-phase synthesis of 2,6,9-trisubstituted purines. Tetrahedron Letters 39(13): 1827-1830
Pitlik, J.; Townsend, C.A. 1997: Solution-phase synthesis of a combinatorial monocyclic beta-lactam library: Potential protease inhibitors. Bioorganic and Medicinal Chemistry Letters 7(24): 3129-3134
Kane, R.R.; Lee, C.S.; Drechsel, K.; Hawthorne, M.F.ederick 1993: Solution-phase synthesis of boron-rich phosphates. Journal of Organic Chemistry 58(12): 3227-3228
Barber, I.; Imbach, J.L.; Rayner, B. 1995: Solution-phase synthesis of phosphorothioate oligodeoxynucleosides by the phosphotriester method. Antisense Research and Development 5(1): 39-47
McAteer, K.; Jing, Y.; Kao, J.; Taylor, J.S.; Kennedy, M.A. 1998: Solution-state structure of a DNA dodecamer duplex containing a Cis-syn thymine cyclobutane dimer, the major UV photoproduct of DNA. Journal of Molecular Biology 282(5): 1013-1032
Van Der Walle, C.F.; Bansal, S.; Barlow, D.J. 1998: Solution-structure of a peptide designed to mimic the C-terminal hexapeptide of endothelin. Journal of Pharmacy and Pharmacology 50(8): 837-844
Akiyama, R.; Kuang, K.; Koniarek, J.P.; Chiaradía, P.A.; Roberts, C.W.; Fischbarg, J. 1997: Solutions containing miotic agents: Effects on corneal transendothelial electrical potential difference. Graefe's Archive for Clinical and Experimental Ophthalmology 235(6): 379-383
Roelfsema, P.R. 1998: Solutions for the binding problem. Zeitschrift für Naturforschung. C Journal of Biosciences 53(7-8): 691-715
Major, G.; Evans, J.D.; Jack, J.J. 1993: Solutions for transients in arbitrarily branching cables: I. Voltage recording with a somatic shunt. Biophysical Journal 65(1): 423-449
Major, G.; Evans, J.D.; Jack, J.J. 1993: Solutions for transients in arbitrarily branching cables: II. Voltage clamp theory. Biophysical Journal 65(1): 450-468
Major, G. 1993: Solutions for transients in arbitrarily branching cables: III. Voltage clamp problems. Biophysical Journal 65(1): 469-491
Major, G.; Evans, J.D. 1994: Solutions for transients in arbitrarily branching cables: IV. Nonuniform electrical parameters. Biophysical Journal 66(3 Pt 1): 615-633
Anderson, J.R.; Henneman, M.C. 1994: Solutions to a tool-use problem in a pair of Cebus apella. Mammalia 58(3): 351-361
Tolkachev, V.; Bershadsky, B.; Nemirko, A. 1993: Solvability of the electrocardiology inverse problem for a moving dipole. Biological Cybernetics 68(3): 253-258
Clarkson, R.B.; Hwang, J.H.; Belford, R.L. 1993: Solvate structures in water-methanol solutions of MRI contrast agents: Electron spin echo envelope modulation in gadolinium chelates. Magnetic Resonance in Medicine 29(4): 521-527
Sussman, F.; Villaverde, M.C.; Davis, A. 1997: Solvation effects are responsible for the reduced inhibitor affinity of some HIV-1 PR mutants. Protein Science: a Publication of the Protein Society 6(5): 1024-1030
Wimley, W.C.; Creamer, T.P.; White, S.H. 1996: Solvation energies of amino acid side chains and backbone in a family of host-guest pentapeptides. Biochemistry 35(16): 5109-5124
Yamaotsu, N.; Moriguchi, I.; Hirono, S. 1995: Solvation free energies of amino acids calculated by molecular dynamics/free energy perturbation method. Chemical and Pharmaceutical Bulletin 43(5): 717-721
Reimann, A.; Robb, D.A.; Halling, P.J. 1994: Solvation of CBZ-amino acid nitrophenyl esters in organic media and the kinetics of their transesterification by subtilisin. Biotechnology and Bioengineering 43(11): 1081-1086
Kranjc, Z.; Lapanje, S. 1993: Solvation of human serum albumin in aqueous alkylurea solutions. International Journal of Peptide and Protein Research 42(4): 320-325
Ben-Naim, A. 1994: Solvation of large molecules: Some exact results on the dependence on volume and surface area of the solute. Biophysical Chemistry 51(2-3): 203-216
Burgess, J.; Drasdo, D.N.; Patel, M.S. 1995: Solvation of platinum anti-cancer drugs in methanol-water mixtures. Biometals: An International Journal on the Role of Metal Ions in Biology Biochemistry and Medicine 8(2): 137-141
Gerothanassis, I., P.; Birlirakis, N.; Sakarellos, C.; Marraud, M. 1992: Solvation state of the Tyr side chain in peptides: An FT-IR and oxygen-17 NMR approach. Journal of the American Chemical Society 114(23): 9043-9047
Marrone, T.J.; Resat, H.; Hodge, C.N.; Chang, C.H.; McCammon, J.A. 1998: Solvation studies of DMP323 and A76928 bound to HIV protease: analysis of water sites using grand canonical Monte Carlo simulations. Protein Science: a Publication of the Protein Society 7(3): 573-579
Cannon, W.R.; Benkovic, S.J. 1998: Solvation, reorganization energy, and biological catalysis. Journal of Biological Chemistry 273(41): 26257-26260
Singh, C.; Sankararamakrishnan, R.; Subramaniam, S.; Jakobsson, E. 1996: Solvation, water permeation, and ionic selectivity of a putative model for the pore region of the voltage-gated sodium channel. Biophysical Journal 71(5): 2276-2288
Barbosa, J.; Berges, R.; Sanz-Nebot, V. 1996: Solvatochromic parameter values and pH in aqueous-organic mixtures used in liquid chromatography: Prediction of retention of a series of quinolones. Journal of Chromatography A 719(1): 27-36
Kukull, W.A.; Larson, E.B.; Bowen, J.D.; McCormick, W.C.; Teri, L.; Pfanschmidt, M.L.; Thompson, J.D.; O'Meara, E.S.; Brenner, D.E.; van Belle, G. 1995: Solvent exposure as a risk factor for Alzheimer's disease: a case-control study. American Journal of Epidemiology 141(11): 1059-71; Discussion 1072-9
Kumarevel, T.S.; Gromiha, M.M.; Ponnuswamy, M.N. 1998: Solvent accessibility analysis on the mutants of Hsc70 ATPase fragment. Biophysical Chemistry 71(2-3): 99-111
Nauchitel, V.; Villaverde, M.C.; Sussman, F. 1995: Solvent accessibility as a predictive tool for the free energy of inhibitor binding to the HIV-1 protease. Protein Science: a Publication of the Protein Society 4(7): 1356-1364
Homoelle, B.J.; Beck, W.F. 1997: Solvent accessibility of the phycocyanobilin chromophore in the alpha subunit of C-phycocyanin: implications for a molecular mechanism for inertial protein-matrix solvation dynamics. Biochemistry 36(42): 12970-12975
Kaliannan, P.; Gromiha, M.M.; Ramamurthi, K.; Elanthiraiyan, M. 1998: Solvent accessibility studies on glycosaminoglycans. Biophysical Chemistry 74(1): 11-22
Palomo, M.E.; Ballesteros, M.P.; Frutos, P. 1996: Solvent and plasticizer influences on ethylcellulose-microcapsules. Journal of Microencapsulation 13(3): 307-318
Santos-Montes, A.; Gonzalo-Lumbreras, R.; Gasco-Lopez, A.I.; Izquierdo-Hornillos, R. 1994: Solvent and solid-phase extraction of natural and synthetic corticoids in human urine. Journal of Chromatography 652(1): 83-89
Sirangelo, I.; Bismuto, E.; Irace, G. 1994: Solvent and thermal denaturation of the acidic compact state of apomyoglobin. Febs Letters 338(1): 11-15
Kleinert, T.; Doster, W.; Leyser, H.; Petry, W.; Schwarz, V.; Settles, M. 1998: Solvent composition and viscosity effects on the kinetics of CO binding to horse myoglobin. Biochemistry 37(2): 717-733
Heffner, J.E.; Wigal, C.T.; Moe, O.A. 1997: Solvent dependence of the one-electron reduction of substituted benzo- and naphthoquinones. Electroanalysis 9(8): 629-640
Rodriguez, L.-Cuadros; Linares, C.-Jimenez; Ceba, M.-Roman 1997: Solvent donicity influence in the fluorescence emission of the lithium/1,4-dihydroxyanthraquinone system. Improvement in the quantification of lithium. Analytical Letters 30(4): 847-866
Friend, D.R.; Smedley, S.I. 1993: Solvent drag in ethanol/ethyl acetate enhanced skin permeation of d-norgestrel. International Journal of Pharmaceutics 97(1-3): 39-46
Rutledge, J.C.; Curry, F.E.; Blanche, P.; Krauss, R.M. 1995: Solvent drag of LDL across mammalian endothelial barriers with increased permeability. American Journal of Physiology 268(5 Part 2): H1982-H1991
Vic, G.; Thomas, D.; Crout, D., H.G. 1997: Solvent effect on enzyme-catalyzed synthesis of beta-D-glucosides using the reverse hydrolysis method: Application to the preparative-scale synthesis of 2-hydroxybenzyl and octyl beta-D-glucopyranosides. Enzyme and Microbial Technology 20(8): 597-603
Hsieh, C.H.; Wu, W.G. 1995: Solvent effect on phosphatidylcholine headgroup dynamics as revealed by the energetics and dynamics of two gel-state bilayer headgroup structures at subzero temperatures. Biophysical Journal 69(1): 4-12
Kuki, M.; Nagae, H.; Cogdell, R., J.; Shimada, K.; Koyama, Y. 1994: Solvent effect on spheroidene in nonpolar and polar solutions and the environment of spheroidene in the light-harvesting complexes of rhodobacter sphaeroides 2.4.1 as revealed by the energy of the A-g- fwdarw -1B-u+ absorption and the frequencies of the vibronically coupled C=C stretching Raman lines in the 1A-g- and 2-1A-g- states. Photochemistry and Photobiology 59(1): 116-124
Giraudi, G.; Baggiani, C. 1993: Solvent effect on testosterone-antitestosterone interaction. Biochimica et Biophysica Acta 1157(2): 211-216
E.N.der, H.M.A.u; Moussa, M.N.H. 1996: Solvent effect on the kinetics of the basic hydrolysis of isatin. Chemical and Pharmaceutical Bulletin 44(9): 1641-1646
Briere, K., M.; Detellier, C. 1992: Solvent effects in the metal interchange of crown ether-alkali metal cation complexes: Transition from an associative exchange in nitromethane to a dissociative exchange in acetonitrile studied by sodium-23 nuclear magnetic resonance. Canadian Journal of Chemistry 70(10): 2536-2543
Waite, J.; Cole, G.M.; Frautschy, S.A.; Connor, D.J.; Thal, L.J. 1992: Solvent effects on beta protein toxicity in vivo. Neurobiology of Aging 13(5): 595-599
Skwierczynski, R.D.; Connors, K.A. 1994: Solvent effects on chemical processes. 8. Demethylation kinetics of aspartame in binary aqueous-organic solvents. Journal of Pharmaceutical Sciences 83(12): 1690-1696
Haouz, A.; Glandieres, J.M.; Zentz, C.; Pin, S.; Ramstein, J.; Tauc, P.; Brochon, J.C.; Alpert, B. 1998: Solvent effects on horse apomyoglobin dynamics. Biochemistry 37(9): 3013-3019
Janssen, A.E.; Van der Padt, A.; Riet, K.V. 1993: Solvent effects on lipase-catalyzed esterification of glycerol and fatty acids. Biotechnology and Bioengineering 42(8): 953-962
Barbosa, J.; Fonrodona, G.; Marques, I.; Sanz Nebot, V.; Toro, I. 1997: Solvent effects on protonation equilibria of peptides and quinolones by factor analysis applied to the correlation between dissociation constants and solvatochromic parameters in acetonitrile-water mixtures. Analytica Chimica Acta 351(1-3): 397-405
Shen, C.L.; Murphy, R.M. 1995: Solvent effects on self-assembly of beta-amyloid peptide. Biophysical Journal 69(2): 640-651
De Carvalho, I.B.; de Sampaio, T.C.; Barreiros, S. 1996: Solvent effects on the catalytic activity of subtilisin suspended in compressed gases. Biotechnology and Bioengineering 49(4): 399-404
De Sampaio, T.C.; Melo, R.B.; Moura, T.F.; Michel, S.; Barreiros, S. 1996: Solvent effects on the catalytic activity of subtilisin suspended in organic solvents. Biotechnology and Bioengineering 50(3): 257-264
Israeli, Y.; Lhermet, C.; Morel, J.-Pierre; Morel-Desrosiers, N. 1996: Solvent effects on the complexation of trivalent lanthanide cations by sugars and alditols: Chromatography-calorimetry comparison. Carbohydrate Research 289: 1-10
Gonnella, N.C.; Zhang, X.; Jin, Y.; Prakash, O.; Paris, C.G.; Kolossváry, I.; Guida, W.C.; Bohacek, R.S.; Vlattas, I.; Sytwu, T. 1994: Solvent effects on the conformation of cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu-). An NMR spectroscopy and molecular modeling study. International Journal of Peptide and Protein Research 43(5): 454-462
Polizio, F.; Bizzarri, A.R.; Cannistraro, S.; Desideri, A. 1997: Solvent effects on the distribution of conformational substates in native and azide reacted Cu, Zn superoxide dismutase. An EPR study. European Biophysics Journal: Ebj 26(4): 291-297
Fransson, J.; Hallén, D.; Florin-Robertsson, E. 1997: Solvent effects on the solubility and physical stability of human insulin-like growth factor I. Pharmaceutical Research 14(5): 606-612
Vazquez-Segura, M., A.; Donoso, J.; Munoz, F.; Fernandez-De-Pierola, I.; Garcia-Blanco, F.; Echevarria, G., R. 1993: Solvent effects on the tautomerization of 5'-deoxypyridoxal: A photophysical study. Photochemistry and Photobiology 57(6): 923-928
Marquart, M.; Jamieson, A.M.; Blackwell, J.; Gerken, T. 1995: Solvent effects on the viscoelastic behavior of porcine submaxillary mucin. Biorheology 32(4): 431-446
Staniewski, J.; Rijks, J.A. 1992: Solvent elimination rate in temperature-programmed injections of large sample volumes in capillary gas chromatography. Journal of Chromatography 623(1): 105-113
Cleland, J.L. 1998: Solvent evaporation processes for the production of controlled release biodegradable microsphere formulations for therapeutics and vaccines. Biotechnology Progress 14(1): 102-107
Rajagopal, P.; Jones, B.E.; Klevit, R.E. 1998: Solvent exchange rates of side-chain amide protons in proteins. Journal of Biomolecular NMR 11(2): 205-212
Zhang, Q.J.; Lindquist, Y.; Levitsky, V.; Masucci, M.G. 1996: Solvent exposed side chains of peptides bound to HLA A*1101 have similar effects on the reactivity of alloantibodies and specific TCR. International Immunology 8(6): 927-938
Seeber, A.; Blaszkewicz, M.; Golka, K.; Kiesswetter, E. 1997: Solvent exposure and ratings of well-being: dose-effect relationships and consistency of data. Environmental Research 73(1-2): 81-91
Rees, D.; Soderlund, N.; Cronje, R.; Song, E.; Kielkowski, D.; Myers, J. 1993: Solvent exposure, alcohol consumption and liver injury in workers manufacturing paint. Scandinavian Journal of Work Environment and Health 19(4): 236-244
Dapaah, A.R.K.; Ayame, A. 1998: Solvent extraction of arsenic from acid medium using zinc hexamethylenedithiocarbamate as an extractant. Analytica Chimica Acta 360(1-3): 43-52
Ogwuegbu, M.O.C.; Oforka, N.C.; Spiff, A.I. 1994: Solvent extraction of iron III with 1-phenyl 1-3-methyl-4-(P-nitrobenzoyl) pyrazol-5-one. Discovery and Innovation 6(2): 158-161
Lazarova, Z.; Peeva, L. 1994: Solvent extraction of lactic acid from aqueous solution. Journal of Biotechnology 32(1): 75-82
Kamburova, M. 1998: Solvent extraction of molybdenum with a new analytical reagent. Analytical Letters 31(13): 2255-2268
Preston, J., S.; Du-Preez, A., C. 1996: Solvent extraction of nickel from acidic solutions using synergistic mixtures containing pyridinecarboxylate esters: Part 1. Systems based on organophosphorus acids. Journal of Chemical Technology and Biotechnology 66(1): 86-94
Gupta, A.; Khopkar, S.M. 1995: Solvent extraction separation of cobalt(II) with hexaacetatocalix(6)arene. Talanta 42(10): 1493-1496
Kang, S.K.; Chung, H.J. 1995: Solvent fractionation of fig leaves and its antimicrobial activity. Agricultural Chemistry and Biotechnology 38(4): 289-292
Chandrasekhar, S.; Takhi, M.; Uma, G. 1997: Solvent free N-alkyl and N-arylimides preparation from anhydrides catalyzed by TaCl5-silica gel. Tetrahedron Letters 38(46): 8089-8092
Bouchard, M.; Auger, M. 1993: Solvent history dependence of gramicidin-lipid interactions: a Raman and infrared spectroscopic study. Biophysical Journal 65(6): 2484-2492
Johansson, I.M.; Forsman, C. 1994: Solvent hydrogen isotope effects and anion inhibition of CO2 hydration catalysed by carbonic anhydrase from Pisum sativum. European Journal of Biochemistry 224(3): 901-907
Kuznetsova, N.; Rau, D.C.; Parsegian, V.A.; Leikin, S. 1997: Solvent hydrogen-bond network in protein self-assembly: solvation of collagen triple helices in nonaqueous solvents. Biophysical Journal 72(1): 353-362
Torres, E.; Tinoco, R.; Vazquez Duhalt, R. 1996: Solvent hydrophobicity predicts biocatalytic behaviour of lignin peroxidase and cytochrome c in aqueous solution of water-miscible organic solvents. Journal of Biotechnology 49(1-3): 59-67
Rosell, A.; Palet, C.; Valiente, M. 1998: Solvent impregnated hollow fibre for a selective preconcentration of Pb(II) on an in-line determination by flame atomic absorption spectrometry. Analytica Chimica Acta 370(2-3): 141-149
Norberg, J.; Nilsson, L. 1998: Solvent influence on base stacking. Biophysical Journal 74(1): 394-402
Nonell, S.; Moncayo, L.; Trull, F.; Amat Guerri, F.; Lissi, E.A.; Soltermann, A.T.; Criado, S.; Garcia, N.A. 1995: Solvent influence on the kinetics of the photodynamic degradation of Trolox, a water-soluble model compound for vitamin E. Journal of Photochemistry and Photobiology B Biology 29(2-3): 157-162
Flanagan, K.; Walshaw, J.; Price, S.L.; Goodfellow, J.M. 1995: Solvent interactions with pi ring systems in proteins. Protein Engineering 8(2): 109-116
Elsing, C.; Hirlinger, A.; Renner, E.L.; Lauterburg, B.H.; Meier, P.J.; Reichen, J. 1995: Solvent isotope effect on bile formation in the rat. Biochemical Journal 307: 175-181
Sepp, A.; Jarv, J. 1993: Solvent isotope effect on the reaction of acetylcholinesterase with alkanesulfonyl halogenides. Bioorganic Chemistry 21(1): 61-70
Cho, Y.K.; Rebholz, K.L.; Northrop, D.B. 1994: Solvent isotope effects on the onset of inhibition of porcine pepsin by pepstatin. Biochemistry 33(32): 9637-9642
Itzhaki, L.S.; Evans, P.A. 1996: Solvent isotope effects on the refolding kinetics of hen egg-white lysozyme. Protein Science: a Publication of the Protein Society 5(1): 140-146
Angeles, T.S.; Roberts, G.A.; Carr, S.A.; Meek, T.D. 1992: Solvent isotope partitioning: A new kinetic tool for the determination of desorption rates of reactant water from enzyme-substrate complexes in proteases. Biochemistry 31(47): 11778-11784
Huang, T.M.; Hung, H.C.; Chang, T.C.; Chang, G.G. 1998: Solvent kinetic isotope effects of human placental alkaline phosphatase in reverse micelles. Biochemical Journal 330: 267-275
Bizzarri, A.R.; Cannistraro, S. 1993: Solvent modulation of the structural heterogeneity in FeIII myoglobin samples: A low temperature EPR investigation. European Biophysics Journal: Ebj 22(4): 259-267
Rothe, M.; Pragst, F. 1995: Solvent optimization for the direct extraction of opiates from hair samples. Journal of Analytical Toxicology 19(4): 236-240
Song, S.; Jahansouz, H.; Himes, R.H. 1993: Solvent oxygen is not incorporated into N10-formyltetrahydrofolate in the reaction catalyzed by N10-formyltetrahydrofolate synthetase. Febs Letters 332(1-2): 150-152
Licata, V.J.; Allewell, N.M. 1998: Solvent perturbation of the allosteric regulation of aspartate transcarbamylase. Biochimica et Biophysica Acta 1384(2): 306-314
Sousa, C.; Sá e Melo, T.; Gèze, M.; Gaullier, J.M.; Mazière, J.C.; Santus, R. 1996: Solvent polarity and pH effects on the spectroscopic properties of neutral red: Application to lysosomal microenvironment probing in living cells. Photochemistry and Photobiology 63(5): 601-607
Kuo, S.J.; Parkin, K.L. 1996: Solvent polarity influences product selectivity of lipase-mediated esterification reactions in microaqueous media. Journal of the American Oil Chemists' Society 73(11): 1427-1433